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INTRODUCTION  
 7 
  Extensive advances have been made in cardiac valve surgery since the first 
artificial valve replacements of the early 1950s. Improved survival after the first 
operation has meant that more patients ultimately require a redo operation at the same site 
and the number of patients will continue to increase as the general population ages. This 
trend reflects many factors, such as the increased life expectancy of the population, the 
decreased overall mortality associated with valvular surgery, and the increasing use of 
bioprostheses which have limited durability because of structural dysfunction. Hence re-
operations are an integral part of the cardiac surgeon’s current daily practice. Among 
heart valves case load, re-operations on prostheses represent between 2.5% and 17% (3). 
Patients requiring heart valve reoperation are diverse in terms of both the initial 
operation and the reoperation and form a very heterogeneous group presenting with a 
variety of clinical conditions including, structural dysfunction of prosthetic valve, 
mechanical valve thrombosis, paravalvular leaks, progression of native valve disease 
after nonvalve surgery and prosthetic valve endocarditis. Reoperations in this group of 
patients are technically more demanding than primary operations because of adhesions 
around the heart with an associated risk of re-entry, the presence of more advanced 
cardiac pathology, and the existence of more frequent co morbidities such as pulmonary 
hypertension. Perhaps most important, reoperations often are performed in functionally 
compromised patients who tolerate complications poorly or who have little reserve.     
Division of the sternum is primarily a blind procedure and carries an increased 
risk of injury for major cardiac structures in the presence of adhesions between the 
posterior table and the innominate vein, right ventricle, and extracardiac conduits and 
grafts. The risk of catastrophic hemorrhage on sternal reentry is estimated to be 0.5% to 
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1% with an associated mortality rate of 21% (21).Resternotomy carries a high risk of 
cardiac injury and subsequent catastrophic hemorrhage.  
More advanced cardiac pathology is associated with increased operative and 
postoperative morbidity and mortality. Re-operations are identified as risks factors for 
blood transfusion requirements, major sternal wound infections and mediastinitis(15). 
As a consequence of the above mentioned factors, reoperative valve surgery 
historically has been associated with a considerably higher operative mortality than 
primary valve surgery. The operative mortality associated with reoperative heart valve 
surgery exceeds the rates than that for the corresponding primary operation. However, the 
risk is higher in certain conditions, such as the presence of prosthetic valve endocarditis 
and the patient being operated on an emergency basis in NYHA functional class IV. It 
may also be increased in the elderly. Reoperations carry a higher risk in most surgeons’ 
experience. 
However, in spite of all these factors, it has been observed that successful 
replacement of the degenerate cardiac valve usually results in gratifying symptomatic and 
hemodynamic improvement even in this group of functionally compromised group of 
patients. 
In this modern era, with use of alternative surgical approaches and advanced 
perioperative care, there has been significant improvement in outcomes. Greater 
awareness of the most dangerous steps and refinements to surgical technique has 
contributed to the decreased mortality. Reductions in operative risk and postoperative 
morbidity after reoperative valve surgery has been achieved through advances in 
myocardial protection, as well as alternative perfusion strategies such as the proper use of 
 9 
deep hypothermic cardiac arrest. In addition, use of peripheral cannulation techniques to 
institute cardiopulmonary bypass has become a relatively standard practice in reoperative 
cases. Early institution of cardiopulmonary bypass prior to reentry is known to prevent 
injury to the distended right ventricle during reoperative sternotomy. In addition, this 
technique reduces myocardial oxygen consumption by decreasing myocardial distension. 
Recent studies have excluded reoperation as a risk factor for operative mortality; 
instead patient characteristics and co morbidities have been identified as determinants of 
operative mortality. We have sought to (1) identify the factors that determine major 
adverse postoperative events (major operative morbidity or mortality) after reoperative 
heart valve replacement, and (2) assess the impact of symptom severity on the outcome 
of cardiac reoperations. 
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AIMS AND OBJECTIVES  
 11 
 
1. To retrospectively evaluate our experience in patients who underwent re-operative 
valve surgery in our institution between January 2000 and December 2009(a period 
of ten years). 
2. To study their manner of presentation, the reasons leading to reoperation, the 
type of surgery performed and operative techniques. 
3. To identify the risk factors for early mortality and morbidity associated with 
these operations. 
4. To study the incidence of late morbidity and functional class at last follow-up. 
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MATERIAL AND METHODS  
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STUDY DESIGN AND INCLUSION CRITERIA: 
 This is a retrospective study of patients who underwent re-operative valve 
surgery between January 2000 and December 2009 in the Department of cardiothoracic 
surgery. In this period, a total of 43 underwent a first reoperation for a new valve problem 
of the native/prosthetic valve. There were 5 operative (30 days) mortalities (11.62%). A 
retrospective review of the hospital inpatient and outpatient charts of the rest of the 38 
patients for their age, sex, presenting symptoms, preoperative NYHA class, preoperative 
risk factors, echocardiogram reports and operative details including surgical approach, 
total aortic cross clamp time, total cardio-pulmonary bypass time, post operative need for 
inotropes and ventilation, number of days of ICU care, post operative complications and 
post operative follow up was performed.(See appendix for proforma of data collection). 
Six patients were lost in the follow-up. 
Patients who had undergone a previous open heart surgery for varied etiologies 
were included in the study. Coronary angiogram was done in all patients older than 40 
years.  
The preoperative characteristics are summarized in Table No: 1 
The mean age was 42.9 years with a range of 12 years to 69 years. 46.5 % of the 
patients were below the age of 40 years and 53.5 % in the study group were above 40 
years. There were 27 males and 16 females. The average interval to reoperation was 12.3 
years with a range of 1 year to 29 years.  
The 43 patients formed a heterogeneous group of patients who had undergone 
previous surgeries for a variety of etiologies and also a variety of surgeries. An 
overwhelming majority of patients (29 patients, 67 %) had a rheumatic etiology and 9 
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patients (20.9 %) had a congenital heart disease as the etiology for the first operation. A 
few among these had developed Rheumatic heart disease or Infective endocarditis 
subsequently necessitating reoperation. The rest 5 patients (11.62 %) had miscellaneous 
etiologies like bicuspid aortic valve, degenerative aortic valve disease, Barlow’s disease. 
The break-up of the first operations that these patients had undergone were as follows: 
Valvotomy/valve repair: 5 
MVR: 12 
AVR: 16  
DVR: 2 
ICR: 9 
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(Table 1) PREOPERATIVE CLINICAL DATA (n=43)                                                              
 
Sl No: Variable 
 
No (%) 
1 Age 
< 40 years 
> 40 years 
42.97 ± 14.53(Range 12-69 years) 
20(46.5%) 
23 (53.5%) 
2 Gender 
Male 
Female 
 
27 (62.89%) 
16 (37.21%) 
3 NYHA class 
Class I 
Class II 
Class III 
Class IV 
 
0 
17(39.54%) 
19 (44.18%) 
7(16.27%) 
4 Cardiac pathology 
RHD 
Congenital heart disease 
Others 
 
 
29(67%) 
9 (20.9%) 
5 (11.62%) 
 
5 Penicillin prophylaxis 
 
10 (31.25%) 
6 Interval to reoperation 
 
12.3 ± 7.08(Range 1-29) 
7 Presence of CCF 
 
9 (20.93%) 
` Rhythm 
Sinus 
Atrial fibrillation 
 
19(44.18%) 
24(55.81%) 
9 LVEF 
>55% 
35-55% 
< 35% 
 
19(44.18%) 
19(44.18%) 
5(11.62%) 
10 History of neurological deficit 
 
3(6.97%) 
11 Presence of renal impairment 
 
6(13.95%) 
12 History of neurological deficit 3(6.97%) 
 
13 First operation 
Valvotomy/valve repair 
MVR 
AVR 
DVR 
ICR 
 
5 
12 
16 
2 
9 
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Male
27
Female
16
<40 years
20
>40 years
23
Gender Age distribution
Demographic Data (n=43)
 
 
Fig 1: Demographic Data 
 
 
 
NYHA status at reoperation (n=43)
II
40%
III
44%
IV
16%
 
 
Fig 2: NYHA status of patients at admission 
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Previous surgical procedure
MVR
28%
AVR
34%
DVR
5%
VALVOTOMY/
REPAIR-12%
ICR
21%
 
Fig 3: Break-up of first surgical procedure 
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Cardiac
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Preoperative cardiac variables(n=43)
 
Fig 4: Preoperative cardiac variables 
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PREOPERATIVE MANAGEMENT:    
 In the preoperative period, 17 patients (39.54 %) were in NYHA class II, 19 
patients (44.18 %) were in NYHA class III and 7 patients (16.27 %) were in NYHA class 
IV. 9 patients (20.93%) were in congestive cardiac failure. All patients were on optimal 
medical management with digoxin and frusemide (injectable in patients who were in 
CCF). 3 (6.9%) patients needed inotropes due to low cardiac output, during the 
preoperative period, one patient with native valve endocarditis, one with late prosthetic 
valve endocarditis and the third with non-structural dysfunction. 2 patients required 
mechanical ventilation in the immediate preoperative period. 6 patients (14%) had renal 
impairment before surgery. Of the 43 patients, 35 patients (81 %) underwent reoperation 
on an elective basis and the rest 8 patients (19 %) underwent reoperation on an 
emergency basis. 
A 5-group classification of indication for reoperation was used, based on an original 4-
group classification by Lytle and associates (10):  
1. Failed repair/new native valve disease: All patients who had a failed previous valve 
repair and patients who at reoperation required repair or replacement of a valve different 
from that operated on during the initial procedure. 
2. Prosthetic valve dysfunction: Valve dysfunction resulting from tissue ingrowths, 
mechanical dysfunction and calcification, and leaflet tears for bioprostheses. This group 
excludes patients with active prosthetic valve endocarditis and thrombosed mechanical 
valves. 
3. Periprosthetic leak: Periprosthetic leak and a normally functioning prosthesis. Patients 
with active endocarditis were excluded.  
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4. Valve thrombosis: Thrombosis of the mechanical valve to the extent that the 
thrombosis interfered with valve opening characteristics. This group does not include 
patients who had embolic phenomena only. 
5. Prosthetic valve endocarditis: Patients with organisms or inflammation documented on 
the valve specimen, or patients who underwent operation while receiving prolonged 
antibiotic treatment for clinical endocarditis. Patients with a history of endocarditis who 
underwent surgery for valve dysfunction that was remote from prolonged antibiotic 
treatment and whose valves showed neither organisms nor active inflammation were 
considered to have “healed endocarditis” and were placed in other groups. 
 
PERIOPERATIVE MANAGEMENT 
Antibiotic protocol followed in all patients included- 
Inj. Cefuroxime 25 mg/ kg per dose (2nd generation cephalosporin) up to a 
maximum of 750 mg/kg/ dose and Inj. Gentamicin 1mg/kg/dose (aminoglycoside).These 
were given with premedication and at induction. It was followed with three daily doses of 
Inj. Cefuroxime 25 mg/ kg per dose (up to a maximum of 750 mg/kg/ dose) for 2 days 
and changed to oral form of the same for another 3 days.  Inj. Gentamicin 3 mg/ kg once 
daily was continued for 5 days.  
INTRAOPERATIVE MANAGEMENT 
Anesthetic management 
Patients were kept nil per mouth for a minimum of six hours for solids and 2 hrs 
for clear fluids prior to surgery. Fentanyl and Sevoflurane were used during induction and 
non- depolarizing muscle relaxant (Vecuronium/Atracurium) was used for neuromuscular 
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blockade. Anaesthesia was maintained with O2, air, and inhalation anaesthetics. Fentanyl 
(5-10 microgram/kg) and Morphine (0.5mg/kg) were given before going on pump in 
order to maintain sedation and analgesia.  
Cardiopulmonary bypass (CPB) 
Polystan, Affinity, Capiox oxygenators were used in our patients. The prime 
volume in the oxygenator was 1200ml (700ML-Ringer lactate solution and 500ml-
Haesteril).Standard femoral arterial and venous cannulae (Chase RMU FEM 11016A 
(Edwards Lifesciences) for femoral artery and Medtronic DLP cannulae (Medtronic Inc, 
Minneapolis, MN for femoral vein) were used for all patients based on body weight. 
Pump flow was maintained between 125-150ml/kg/mt, and blood gases were adjusted 
according to the pH stat strategy. During initiation of CPB mannitol (0.5 g/kg) and 
sodium bicarbonate (1ml/kg) were given. After initiation of CPB, moderate hypothermia 
(28-32 deg C) was induced and aorta was cross clamped. Heart was arrested by giving 
cold blood cardioplegia (St. Thomas I cardioplegia solution with procaine) through the 
aortic root/ostia as situation demanded. Ice slush was used for myocardial protection after 
cardiac arrest. The left side venting in aortic valve replacement s were accomplished by a 
left atrial vent inserted through the RSPV. The same dose of mannitol and sodium 
bicarbonate were given during rewarming. When rectal temperatures reached 36deg C, 
the patients were weaned off bypass. 
SURGICAL TECHNIQUE 
All patients were operated on in the surgical unit, by the same senior surgeon. Our 
unit protocol is institution of femoro-femoral bypass followed by sternal re-entry for all 
re-operative surgery. Through a right femoral incision, the right femoral artery and vein 
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was exposed, taped and prepared for cannulation. Simultaneously the skin incision on the 
chest was made on the previous sternotomy incision and excising the scar tissue as well. 
The sternal wires were untwisted and removed. The incision line on the sternum was 
marked by electrocautery. Heparin was administrated at a dosage of 3.0 mg/kg. The 
activated clotting time was kept more than 480 seconds. First, the venous cannula was 
inserted. We use Medtronic DLP cannulae (Medtronic Inc, Minneapolis, MN) routinely. 
First, we advanced guidewire through the femoral vein into the right atrium. Then 
transverse venotomy was performed, and the cannula and its obturator were slipped over 
the guidewire without any difficulty into the right atrium and superior vena cava. The 
guidewire and cannula obturator were removed, and the venous cannula was connected to 
the venous line of the pump. The prepared femoral artery was carefully palpated to 
recognize any atherosclerotic changes. The softest part of the femoral artery was chosen, 
and the guidewire was advanced into the femoral artery through a needle. When the 
guidewire was advanced into the arterial system without difficulty, then arterial clamps 
were placed and transverse arteriotomy was performed. We use Chase RMU FEM 
11016A (Edwards Lifesciences) for arterial cannulation. Both the arterial cannula and its 
obturator were advanced into the femoral artery. Cardiopulmonary bypass was 
established without difficulty in all cases. Optimal flow could be maintained in all 
patients. Body temperature was reduced, and optimal flow was pumped according to the 
lowered body temperature. We generally did not cool patients to less than 32°C during 
the sternal re-entry to avoid development of heart fibrillation, which might cause heart 
distension and compel safer heart dissection. 
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Sternal re-entry:  
An oscillating saw was used in all patients for sternal re-entry. After the 
resternotomy was completed, first the left part of the sternum was slightly elevated by the 
second assistant and then the adhesions beneath the sternum could be dissected by 
electrocautery. The left pleurotomy was routinely performed if it had not been done 
previously. Immediately after the completion of the dissection of the left part of the 
sternum, the right part was dissected similarly. We preferred sharp dissection to free the 
cardio-pericardial adhesions. When the planned procedure was a MVR, the whole heart 
was freed. The aorta was dissected to facilitate placement of both the aortic cross-clamp 
and the antegrade cardioplegia cannula. Venting of the left ventricle where necessary was 
accomplished by a cannula placed in the right superior pulmonary vein or through the 
PA. In cases of MVR or DVR, a separate cannulation of the SVC was done using a 
Pacifico cannula and connected to the venous line.  
The CPB was instituted using membrane oxygenators, and moderate systemic 
hypothermia was employed routinely. Myocardial protection was achieved using cold 
blood potassium rich cardioplegia through the root cannula or direct coronary ostial 
cannulae using modified St. Thomas’ solution, and repeated every 20-25 min. An 
improved protection of the ventricles was provided by the use of topical hypothermia 
with ice slush. In the majority of patients, a Medtronic valve was placed in the aortic 
position while the preferred valve in the mitral position was a St Jude Medical valve. 
Interrupted horizontal mattress sutures with Teflon pledgets were utilized for both mitral 
and aortic valve implants. 
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Fig 5: Use of an oscillating saw for sternal re-entry 
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Fig 6: Extensive cardio pericardial adhesions 
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Aortic valve replacement:  
The aorta was cross clamped, oblique aortotomy made, and antegrade 
cardioplegia was infused using ostial cannulae. Aortotomy extended. The aortic valve 
was completely excised. The prosthetic/native aortic valve was then excised. The valve 
was sized and the desired prosthetic valve was placed using interrupted horizontal 
mattress sutures with Teflon pledgets. The leaflet was checked for mobility. The aorta 
closed in 2 layers with 4-0 prolene. With the head end lowered, and with the root on 
suction, the cross clamp was released. Once the heart was beating well, the LV vent was 
removed.  The aortic root cannula was then taken out and the aorta repaired. Two 
temporary epicardial pacing wires are placed on the RV surface.  Inotropic support (Inj. 
Adrenaline) is commenced and patient weaned off bypass. Protamine was administered 
for complete heparin reversal. Drains were placed and hemostasis secured. Sternal wires 
were taken, followed by standard closure. The femoral cannulation sites were repaired 
with 5-0 prolene, the dissection site hemostasis achieved and wound was closed in layers. 
The patient was then transferred to the ICU with endotracheal tube in place. 
Mitral valve replacement:  
The aorta was cross clamped and a left atriotomy was made. Cold blood 
cardioplegia was infused through the root cannula.  SVC snared. The left atriotomy was 
then extended. The mitral valve was inspected. The prosthetic / native diseased mitral 
valve was excised leaving behind most of the posterior leaflet. . The valve was sized and 
the desired prosthetic valve was placed using interrupted horizontal mattress sutures with 
Teflon pledgets. Fogarty catheter was introduced to make it incompetent.  Left atriotomy 
closed in 2 layers. With root on suction the cross clamps were released. A minimal 
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inotropic support was commenced, 2 pacing wires were put on the heart. Once the heart 
was beating well, the Fogarty was removed and the LA repaired. The patient was weaned 
of bypass. The SVC cannula was clamped and removed. The cannulation site was 
repaired. The root cannula was taken off and the aorta repaired. Protamine was 
administered for complete heparin reversal followed by decannulation. Drains were 
placed and hemostasis secured. Sternal wires were taken, followed by standard closure. 
The femoral cannulation sites were repaired with 5-0 prolene, the dissection site 
hemostasis achieved and wound was closed in layers. The patient was then transferred to 
the ICU with endotracheal tube in place.                                                                                                                                                                    
POSTOPERATIVE MANAGEMENT 
Ventilation was accomplished with the Servo Ventilator (Siemens- Elema AB, 
Solna, Sweden) in all patients.  Patients were ventilated in the pressure controlled mode 
with a tidal volume of 10-12ml/ kg.  The minimum inspired oxygen fraction that provides 
acceptable arterial oxygen saturation was used (usually 50% of oxygen). 
Sedation and analgesia consisted of intermittent boluses of injection Morphine.  
Neuromuscular blockade was achieved with intermittent boluses of Vecuronium if 
needed. 
Hemoglobin value and serum electrolytes were checked and arterial blood gases 
analyzed in all patients at arrival to the ICU and appropriately corrected.  A bed side 
chest roentgenogram was obtained to confirm the correct position of the endotracheal 
tube, drains, invasive monitoring lines and also to rule out pleural or pericardial 
collection or pneumothorax and acted appropriately. A pulse oximeter was used to 
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continuously monitor the perfusion of the lower limb which was used for vascular access 
during bypass. 
         The patient was extubated the next day morning if extubation criteria were satisfied. 
Inotropic dosage was adjusted according to the hemodynamic status and all the inotropes 
were usually continued till the time of extubation. The inotropic agents used in our 
patients were Adrenaline, Calcium gluconate, Dopamine as necessary. All the inotropes 
were gradually tapered over the next 24 hours provided the patient was hemodynamically 
stable. 
ANTICOAGULATION 
Postoperatively all patients received anticoagulation with  Warfarin Sodium, 
aiming at an international normalized ratio of 2.0 to 3.0 for AVR and 2.5 to 3.5 for MVR.  
Prior to the use of the International normalized ratio for titration of anticoagulation, 
routine prothrombin time was performed in patients to assess the level of anticoagulation.  
Antiplatelet drugs (Aspirin-150mg) were routinely started on the 4th postoperative day or 
earlier if the operation had entailed removal of a left atrial clot. 
DEFINITIONS  
In accordance with STS guidelines and its 2008 modifications (1,2), early 
operative mortality was defined as death occurring within 30 days of operation or 
before discharge from the hospital. Any abnormality resulting in stenosis or regurgitation 
of the aortic valve that was not intrinsic to the valve itself, such as pannus in growth, 
trauma, or surgical error, was considered non-structural dysfunction. In contrast, 
structural dysfunction was a change in valve function related to an intrinsic abnormality 
causing stenosis or regurgitation, such as calcification and leaflet tears. Any abnormality 
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that caused malfunction of the prosthetic valve that was deemed significant by the 
referring physician and operating surgeon and that was not caused by structural or non-
structural dysfunction was classified as clinical dysfunction. Patients with preoperative 
serum creatinine level of 1.4 mg/dL or greater were considered to have renal 
insufficiency, whereas postoperative renal insufficiency was defined by a rise of 
creatinine level to 2.0 mg/dL or greater. Requirement for dialysis was considered a 
complication of surgery only if preoperative renal function was normal. Myocardial 
infarction was defined by the presence of these three criteria: (1) enzyme (creatine 
kinase MB fraction and troponin T) level elevation (2) serial electrocardiogram with ST-
T segment changes or pathologic Q waves and (3) new occurrence of regional 
hypokinesia or dyskinesia. 
 Operations were considered emergency if patients had symptoms necessitating 
hospitalization for evaluation and admission to ICU for stabilisation, if operations were 
performed for cardiovascular instability necessitating a procedure outside the normal 
operative schedule or if another patient was displaced from a scheduled operation. 
Neurologic symptoms lasting less than 1 hour and neurologic deficits that resolved 
within 72 hours were considered transient neurologic deficits, whereas stroke was a 
central neurologic deficit persisting longer than 72 hours. Gastrointestinal complications 
included gastrointestinal bleeding necessitating transfusion or a change in anticoagulation 
protocol, cholecystitis necessitating cholecystotomy drainage or surgical intervention, 
pancreatitis according to elevated pancreatic enzymes, or ischemic or gangrenous bowel 
requiring surgical resection. Sternal wound infection was marked by antibiotic use, 
incision and drainage, or a positive wound culture. Pulmonary complications were 
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defined by the occurrence of new respiratory tract infections, pleural effusions, 
requirement of reintubation and requirement of tracheostomy. 
STATISTICAL ANALYSIS 
Perioperative data were collected through retrospective review of hospital records. 
Outcome analysis included early mortality (defined as death during postoperative 
hospitalization) and morbidity, cardiopulmonary bypass time, aortic cross clamp time, 
mean duration of ICU stay, total number of days stay in hospital and postoperative follow 
up at the end of six months and at last follow-up were also reviewed. Those who did not 
come for regular follow up were enquired about their status by postal letter and 
telephonic interview. Data are expressed as mean values, standard deviations, range and 
interquartile range.  
All study variables were summarized either using frequencies and percentages or 
using means and standard deviations. Bar and pie charts were obtained to represent 
percentages using Excel applications. Univariate analysis was performed using the Chi-
square test and a p- value of less than 0.05 was considered statistically significant. 
Variables associated with P <0.05 on univariate analysis were included for multivariate 
analysis. Statistical processes were conducted with SPSS 16.0 for Windows package 
(SPSS Inc., Chicago. 
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Reoperations on cardiac valves have become increasingly frequent, in proportion to the 
number of patients in whom valve prostheses have been implanted in the past four 
decades. Thromboembolic complications in mechanical prostheses and structural failure 
of the same and of bioprostheses are usually time-related. As the time since implantation 
elapses, more cases will come to reoperation. Reoperations are certainly more difficult 
than the initial procedures and are still associated with major adverse events, most of 
which are predictable and can occur despite careful attempts to avoid them. Reoperations 
are technically demanding, and many patients present in a poor functional state that 
further increases their mortality, in some series up to 19%(10). Generally speaking, 
optimal planning for reoperation prior to deterioration to NYHA class III–IV levels and 
before unfavorable co morbid conditions have arisen is imperative to ensure good 
outcomes(7). Hence in the modern era, elective reoperation for malfunctioning native / 
prosthetic valves can be performed with results similar to those of the primary operation. 
There are key differences between reoperative surgery and routine practice in non 
reoperative patients at every stage from patient selection and assessment, through to the 
sequence and technical aspects of the operation. Valvular reoperations encompasses a 
wide variety of concerns, including proper planning of the operation, re-entry into the 
mediastinum and the pericardial cavity, techniques of cardiopulmonary bypass, access to 
the faulty prosthesis, treatment or removal of this prosthesis, and  minimizing 
hemorrhage and blood saving. Understanding not only the surgical plan but also the 
potential rescue strategies in the event of major intraoperative complications is vital for 
the entire surgical team. Whereas in the nonreoperative setting many automatisms within 
an institution develop allowing reflex-like management of the patient, this cannot apply 
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to reoperative cardiac surgery if a successful outcome is to be expected. Risk stratifying 
reoperative patients allows the team to develop a strategy tailor-made for the needs of the 
individual patient 
PREOPERATIVE ASSESSMENT 
 In addition to a comprehensive cardiovascular and previous medical history, a 
detailed account of the previous cardiac surgery, including date and nature of operations, 
incisions used, and postoperative complications, particularly regarding respiratory failure, 
tracheotomy, and sternal wound infections, should be obtained. A history of mediastinal 
sepsis or irradiation, multiple cardiotomies, cardiac surgery within 3 weeks to 6 months 
when adhesions are at their densest, pericardiectomy, or prosthetic material such as assist 
devices or prosthetic grafts is associated with particularly challenging resternotomy and 
dissection. Previous thoracic surgery makes a thoracotomy approach difficult. In addition 
to the routine focused preoperative physical exam, wound location and healing and 
potential sites of peripheral cannulation in the groin and axilla should be assessed for 
scars and patency. The operative report from the initial surgery should be obtained and 
reviewed to ascertain the incision and cannulation sites, the number, location, and valve 
types and sizes implanted and the technique of suture. It is also important to know 
whether or not the pericardium was closed during the initial operation. The postoperative 
history is critical; a mediastinal infection, for example, is likely to produce more 
adhesions in the retro-sternal space and, therefore, makes the procedure more difficult 
and dangerous, unless special precautions are taken. However it is often seen in every 
surgeon’s practice where the operative report is not available and the patient do not know 
what surgery was performed previously. 
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Prior to proceeding with a resternotomy, the relationship between certain anterior 
mediastinal structures (e.g., the right ventricle and the aorta) and the posterior aspect of 
the sternum must be assessed carefully. This generally can be visualized on chest 
radiograph or more accurately with a computed tomography (CT) scan (7,13). The chest 
X-ray (left lateral view)(13) will reliably show the number of wire used in the previous 
operation and whether the right ventricle is against the sternum, in which case it is safer 
to institute cardiopulmonary bypass prior to sternal re-entry. The most recent technology 
employs multidetector computed tomography (MDCT) scanning(13), in combination 
with retrospective electrocardiographic gating as a noninvasive way to assess not only the 
heart’s location in relation to the sternum but also graft location and patency. CT 
angiography of the chest or magnetic resonance angiography(13) both provide useful 
additional information about the proximity to the sternal incision of various structures, 
including the aorta, right ventricle, pulmonary artery, and  allow assessment of the caliber 
of the aorta, and suitability of sites for cannulation and clamping, which may be further 
enhanced by 3 –dimensional reconstruction. Valuable information regarding the location 
of cardiac and large vascular structures can be obtained from a non contrast chest CT in 
patients with a contraindication to constrast (such as allergy or renal insufficiency) or 
who do not have a history of prior bypass grafting. There may be evidence of previous 
surgery associated with dense adhesions in the form of pledgets, or any synthetic 
material. If these areas involve, or are in close proximity to, the atrium or the aorta, there 
is a higher risk of injury to these sites, and an extra thoracic option for cannulations 
should be planned. In patients with renal insufficiency or prior mediastinal irradiation, a  
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Risk category 
 
Preoperative assessment Intra-operative strategy 
 
 
 
 
Low risk resternotomy 
 
 
Prior Cardiac surgery without 
patient coronaries 
Aorta mediastinal structures a 
safe distance from the sternum, 
clearly shown in the non-contrast 
CT Chest opposite 
 
Sternotomy, Mediastinal 
dissection, standard aorta-caval 
cannulation, initiate bypass, 
proceed with residual dissection, 
cross clamp as indicated and 
perform procedure  
Optional: expose potential 
peripheral cannulation sites prior 
to sternotomy 
 
 
 
 
Medium risk 
resternotomy 
 
Patient vein grafts that lie a 
safe distance from the sternum 
Patient LIMA to LAD graft 
that lies laterally (arrowed in the 
3D reconstruction of a CT 
angiogram opposite) 
 
Peripheral arterial cannulation 
performed (need 5000 units of 
heparin). Sternum is then opened 
and dissection proceeds as above 
(if injury to vital structure occurs 
then bypass instituted using pump 
suckers until venous cannulation 
can be obtained). 
Optional: arterial and venous 
cannulation with full 
heparinization prior to sternotomy 
 
 
 
 
 
High risk resternotomy 
 
Mammary artery crossing the 
midline close to sternum (arrowed 
in the CT angiogram opposite) 
with some native or collateral 
protection 
Right ventricle adherent to the 
sternum 
Normal aorta in close 
proximity to the sternum 
Peripheral arterial and venous 
cannulation, with full 
heparinisation prior to 
sternotomy, with dissection as 
described above 
Optional: Institute 
cardiopulmonary bypass and 
drain patient prior to sternotomy 
 
 
 
Very high risk 
resternotomy 
 
Mammary artery crossing the 
midline close to sternum, with no 
collateral flow 
Aortic tube graft or 
pseudoaneurysms adhrent to 
sternum 
Peripheral arterial and venous 
cannulation, with full 
heparinisation and institution of 
bypass, cooling and deep 
hypothermic circulatory arrest to 
open sternum. 
 
Table 2: Risk stratification of low, medium, high and very high sternotomies with a 
summary of operative strategy tailored to address risks. (Adapted from Akujuo A, 
Fischer GW, Chikwe JC: Current Concepts in Reoperative Cardiac Surgery. 
Seminars in Cardiothorac Vasc Anaes 2009 13(4) 206-14) 
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noncontrast CT scan of the chest may be indicated to identify calcification of the 
ascending aorta. 
In addition to standard preoperative studies, venous ultrasound studies to assess 
central venous access are advisable because previous central line placement can lead to 
central venous stenosis and occlusion.  
 Based on the above information, the reoperation may be stratified as low risk, 
moderate risk, high risk, or very high risk for adverse events (13). This risk stratification 
informs the choice of operative and to a certain extent, anesthetic strategies. 
PRIOR TO INDUCTION 
From an anesthetic standpoint no additional laboratory values are required solely 
because the surgery is reoperative. It may also be beneficial to withhold angiotensin-
converting enzyme inhibitors for 48 hours before reoperative cardiac surgery, in view of 
the longer bypass times and increased risk of vasoplegia in the postoperative period. 
Concerns regarding airway management are always present regardless of the number of 
times the patient has come for previous surgeries. The ability to provide lung separation 
is very helpful if a thoracotomy approach, which may be indicated when resternotomy is 
very high risk, is planned (5). 
Adhesive external defibrillator paddles (14) should be applied prior to induction 
and remain on the patient throughout the case because internal paddles cannot be used to 
defibrillate the heart until the mediastinal dissection, which itself can trigger ventricular 
tachycardias, has been completed. The positioning of the external paddles should be 
discussed with the surgeon as standard placement may compromise the surgical field, 
which not infrequently requires other access than a standard median sternotomy. Many 
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patients presenting for reoperative surgery have internal pacemaker devices or automatic 
internal defibrillator devices in place. The functionality of the pacemaker should be 
checked prior to surgery; it is helpful to know what make of device is in situ because that 
dictates the make of programming device used to interrogate the pacemaker. The 
treatment mode of the AICD (automatic implantable cardioverter defibrillator) needs to 
be turned to off, either by using a programmer or by placing a magnet over the device 
(13). Once deactivated, the patient should be kept in a monitored setting with the external 
defibrillator pads applied until the device can be reactivated and checked. 
Previous scars, including the primary incisions, sites of drains, and extrathoracic 
cannulation should be marked clearly, and it may also be helpful to mark the femoral 
pulses in case emergent femoral cannulation is required. The patient should be  prepped 
and draped in such a way that access is readily available within the sterile field to extra 
thoracic cannulation sites (axillary and femoral), conduit harvest, and permanent 
pacemakers and defibrillators. Between 5 and 10 g of aminocaproic acid may be 
administered intravenously prior to incision (14). 
Because of the fact that the potential for rapid blood loss is constantly present, 
and there may be a considerable delay in achieving surgical access with the ability to 
transfuse from the bypass circuit, large – bore venous access, normally with the side arm 
of the introducer, is essential to guarantee timely volume substitution, and this should be 
obtained using ultrasound guidance as outlined above. As a consequence of prolonged 
bypass times, difficult cardio- protection, and frequently increased requirements for 
inotropic and vasopressor support while weaning from bypass, it is prudent to insert 2 
indwelling arterial catheters at the beginning of the case. Because of the frequently 
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encountered blunting of peripheral arterial tracings, 1 arterial catheter should be placed in 
a large central artery (femoral or axillary artery). If axillary cannulation is planned contra 
lateral arterial catheters should be placed, with an additional ipsilateral catheter if 
cannulation via s side graft is planned (see below). Some surgeons request placement of a 
16F catheter in the femoral vein and or artery, so that if it becomes necessary to go on 
bypass emergently, the catheters may be changed over guide wires to femoral cannulae. 
By pass lines should be brought up to the field and the pump primed prior to sternotomy, 
irrespective of whether cannulation is carried out prior to sternotomy or once the 
mediastinal dissection has been completed (13). 
ANESTHESIA 
Both balanced and high-dose narcotic techniques can be used in the reoperative 
setting, and this is primarily left to the discretion of the anesthesiologist. Particular 
attention must be paid to those patients at high risk of cardio vascular collapse during 
induction, such as patients with critical aortic stenosis, or tamponade. These patients can 
decompensate extremely rapidly, and because surgical access is so difficult, they are 
significantly more difficult than nonreoperative patients to salvage once this has 
happened. 
SURGICAL APPROACH 
 Fundamental to a flawless surgical procedure is excellent and consistent exposure 
of the valve in question. Historically, the mitral valve has been exposed through a variety 
of surgical approaches, including median sternotomy, right thoracotomy, left 
thoracotomy, and transverse sternotomy (5). The aortic valve has been consistently 
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exposed through a median sternotomy. Minimally invasive techniques have been used for 
both valves. 
Median sternotomy   
Resternotomy is still the most common approach in reoperative valve surgery. In 
many cases, this incision provides full and adequate exposure. This is especially true 
when concomitant procedures are necessary. However, reoperative median sternotomy 
has known risks, including inadvertent cardiac injury, sternal dehiscence, excessive 
hemorrhage and injury to or embolism from prior grafts. Patients with valvular heart 
disease may be especially prone to these complications because atrial dilatation can result 
in significant cardiomegaly, atrial thinning, and adherence of the heart to the posterior 
sternum (21). 
Technique 
Sternal re-entry can be performed using a technique similar to that used in the 
initial operation which will hitherto be referred as a conventional sternotomy or after 
instituting cardiopulmonary bypass. Hence exposure of the femoral vessels and 
preparation for emergency femoral-femoral cardiopulmonary bypass should be always be 
considered and kept ready prior to resternotomy. The sternal skin incision is usually made 
in the standard fashion, unless local infection or keloid scarring requires excision of the 
scar. Electrocautery is used to dissect down to the sterna wires. Sternal wires from the 
previous operation should be carefully untwisted, cut and bent to the sides, but left in 
place as a safeguard during initial sternal division. Some surgeons leave the sternal wires 
in situ posterior to the sternum to act as a “guard” for the saw with the hope of protecting 
the mediastinal structures. The disadvantages of leaving the wires in situ are, first, the 
 39 
likelihood of blunting the saw during the sternotomy and second, if a critical structure is 
injured during the sternotomy, which is possible despite leaving the wires in situ, the 
surgeon then has to deal with multiple fragments of wire which can cause additional 
lacerations, prior to addressing the acute problem. 
 The soft tissue at the sternal notch is dissected. Electrocautery and sharp 
dissection may then by used to dissect the xiphoid process away from the heart. The 
assistant used either handheld retractors at the sterna notch and the xiphoid or periosteal 
sutures to gently elevate the sternum. This may help increase the distance between the 
saw blade and the mediastinal structures. Some surgeons elect to perform an initial 
dissection under the sternum using thoracoscopic guidance. In very-high-risk cases, a 
small transverse incision may be made in the second or thirds intercostals space to allow 
the aorta to be dissected free from the sternum prior to the median sternotomy (13).   
An oscillating (not reciprocating) bone saw should be used to divide the anterior 
sternal table and the intermediate space in a caudal-cranial direction. Most authors 
recommend dividing the mediastinal or posterior table under direct visualization using a 
combination of cutting with a straight Mayo scissors and anterolateral rake retraction. in 
order to prevent perforation of the right ventricle or the right atrium when they are 
enlarged. Another method is the use of the stryker saw (14), starting from below, while 
the first assistant holds the rake retractors, pulling the sternum upwards. 
The posterior table is then divided along then entire length also in a caudal – 
cranial direction, either with the oscillating saw or using straight mayo scissors facilitated 
by an assistant progressively splinting open the sternum with a retractor. Two to three 
centimeters of the sternum are cut at a time, and the dissection progresses upwards until 
 40 
the sternum is completely open. This part of the sternotomy poses the most risk to 
underlying structures, and in addition to attempting to elevate the sternum, surgeons may 
try to decompress the mediastinal structures by holding ventilation or, in the case of 
patients who have been cannulated, allowing the perfusionist to exsanguinate the patient 
into the pump temporarily. Very occasionally, the safest option will be to go on 
cardiopulmonary by pass, cool the patient down, and arrest the circulation prior to 
sternotomy. Once the sternotomy is completed, the wires may be removed if they were 
left in situ. 
Dissection 
The sub-xiphoid space is dissected with scissors, separating the pericardium and/ 
or the heart from the back of the sternum. Assuming that the ventricle has not been 
injured, the adhesions behind the sternum are then dissected further laterally, using 
scissors or electrocautery. Using electrocautery, fibrous structures at the notch are 
released. This should be done carefully to avoid injury to the innominate vein. 
Meticulous hemostasis of the sternum and soft tissue should then be performed. 
Electrocautery is used to dissect the heart away from the left sternal edge, 
followed by the right sternal edge. Retraction of the sternal edges at this time is 
performed cautiously to avoid right ventricular rupture from excessive traction. Care 
should be taken to keep the plane of dissection close to the sternum to avoid injury to the 
cardiac structures, which places the in situ mammary artery or vein at slightly increased 
risk of injury, especially at the superior aspect of the sternum on the right where they lie 
medially. Only about an inch is needed at each side of the sternum to allow a sternal 
retractor to be placed, but more extensive dissection is best done after a precocious 
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bilateral pleurotomy starting inferiorly (14). This ensures that the right ventricle, which 
adheres to the anterior mediastinal structures, is not placed under excessive tension when 
the retractor is opened. 
 This is followed by careful dissection of other mediastinal structures. The 
primary goal of subsequent mediastinal dissection is to free potential cannulation sites 
namely, the aorta and right atrium- and the superior and inferior vena cava, if mitral or 
tricuspid surgery is planned and if patients have not been peripherally cannulated prior to 
sternotomy, as well as a cross-clamp site.  The pericardial space is then entered. If from 
the previous notes, it is known that the pericardium was closed at the end of the previous 
operation, then the small window in the lower part of the mediastinum where the serosa 
was not completely closed for passage of the drain is searched for and defined. This 
window is easily identified because of the bulging of the congested right ventricle. 
Sometimes the previous suture line can be seen. However, if the pericardium was not 
closed in the previous operation, its edges will be found more laterally. Here the 
pericardial dissection plane should be developed by starting at the cardiophrenic angle 
and advancing slowly cephalad and laterally on the surface of the right side of the heart. 
Cephalad dissection should start with freeing the innominate vein prior to spreading the 
retractor to avoid its injury. Further dissection then is carried down to the superior vena 
cava, being careful to note the location of the right phrenic nerve. An area of consistently 
dense adhesions is the right atrial appendage, and caution should be used here. If there 
are extensive adhesions to the right atrium, it is reasonable to leave a piece of 
pericardium on the atrium to avoid injury. Excessive manipulation of an atherosclerotic 
aorta should also be avoided. In addition, particular care should be taken to avoid 
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"deadventializing" the aorta which predisposes to aortic rupture(19). The area where the 
aorta apposes the pulmonary artery is another site of potential injury. 
To help keep hemorrhagic complications to a minimum, dissection of the 
pericardium over the left side of the heart is avoided and limited to the area over the aorta 
and main pulmonary artery, where the aortic cross -clamp is to be applied. On the other 
hand, complete dissection of the right side over the lateral wall of the right atrium, is 
essential, especially for mitral valve procedures. It is also required for aortic procedures, 
if venting of the left ventricle is done through the right superior pulmonary vein and left 
atrium. In severely congested patients, the dilated right atrium often complicates 
dissection, and it may be easier to commence bypass with the arterial cannula in the aorta 
and one single drain in the right atrium to decompress the heart. This may also be done in 
emergency situations once the aortic area and the right atria1 appendage are exposed. The 
aorta is always easily identifiable and the atria1 cavity can also be rapidly reached 
through the right pleural cavity, entered immediately after the sternal split. Electrocautery 
may be used for dissection as this may improve hemostasis. It is important, however, to 
stay in the appropriate planes because cauterization of the ventricle may result in 
ventricular arrhythmias, in addition to tissue trauma. Most importantly, as much 
dissection as is safe should be done prior to heparinization and bypass initiation, although 
decompressing the heart greatly facilitates most dissection.  
The incidence of resternotomy hemorrhage is between 2% and 6% per patient 
reoperation(22). Prevention of this ominous complication by interposition of pericardium 
or other mediastinal tissue at the time of the first operation has been suggested 10) but 
has debatable relevance. Active hemorrhage during a second sternotomy usually is due to 
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adherence of the heart or great vessels to the posterior sternum(20). When major 
hemorrhage does occur on sternal entry, attempts at resternotomy should be abandoned, 
and the chest should be reapproximated by pushing toward the midline. The patient 
should be heparinised immediately while obtaining femoral arterial and venous 
cannulation. Blood loss from the resternotomy should be aspirated with cardiotomy 
suction and returned to the pump. Once bypass has been established, core cooling should 
be commenced with anticipation of the need for circulatory arrest. Once cool, flow rates 
can be reduced, and the remaining sternal division can be completed, followed by direct 
repair of the underlying injury. In cases of heightened concern for right ventricle or graft 
injury, or in patients with a patent LIMA to left anterior descending (LAD) artery graft, 
cardiopulmonary bypass and cardiac decompression should be initiated prior to sternal 
reentry. After safe sternal entry, the patient may be weaned from bypass for further 
dissection of adhesions to avoid prolonged pump times.  Repair of small ventricular or 
atrial lacerations should not be attempted before releasing the tension of the surrounding 
adhesions. Repair of great vessel injuries or severe right ventricle injuries is best done 
under cardiopulmonary bypass.  
In general, in the setting of reoperative surgery, though resternotomy is the most 
commonly used method, it is also the most dangerous part of the operation.                                
Thus came into use alternate techniques that avoid resternotomy, such as right 
thoracotomy.   
Right thoracotomy 
The right anterolateral thoracotomy approach was one of the first surgical 
approaches to the mitral valve, and it has become a safe alternative to resternotomy for 
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mitral valve replacement. This approach provides excellent exposure of the valves (mitral 
and tricuspid) with minimal need for dissection within the pericardium. Patients with 
previous aortic valve replacements can have difficult exposure of the mitral valve owing 
to anterior fixation and probably are best served by a right anterolateral thoracotomy 
approach(5). 
Technique 
All patients are intubated using double-lumen endotracheal tubes and operations 
were performed in the right lateral thoracotomy position. The right groin is prepared for a 
femoral cannulation, if necessary. A right thoracotomy was made, and the chest was 
entered through the bed of the fourth or fifth rib. Adhesions of the right lung to the chest 
wall or pericardium were divided by electrocautery. The pericardium is entered anterior 
to the phrenic nerve. Arterial cannulation was performed via the ascending aorta with the 
use of a flexible aortic cannula or, alternatively, through the groin. Bicaval venous 
cannulation was carried out using flexible venous cannula in the inferior vena cava. 
Patients then are cooled to 20 to 25°C. Fibrillatory arrest occurs spontaneously in the 
majority of patients. If care is used to avoid left ventricular ejection by keeping the left 
ventricle empty (i.e, maintaining laminar, nonpulsatile arterial line tracing), a beating-
heart technique also may be used. In the absence of aortic insufficiency, aortic cross-
clamping usually is not required. Regurgitant flow through the aortic valve occasionally 
may require temporary low pump flow at appropriate temperatures to avoid cerebral 
injury. The mitral valve then was approached through the left atrium directly by 
dissection of the intra-atrial (Sondergaard’s) groove or through the right atrium via the 
atrial septum. As the valve procedure was completed, rewarming was initiated. Perfusing 
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blood via a cannula (e.g., the left ventricular vent) positioned across the mitral valve and 
into the left ventricle will serve to displace residual air. An aortic root vent kept on 
suction in the ascending aorta is used to remove any ejected air. Patients should then be 
placed in the Trendelenburg position and de-airing ascertained under 2D TEE guidance. 
When core temperatures reached 37°C, the patient is weaned from cardiopulmonary 
bypass. Temporary atrial and ventricular pacing wires were placed and exteriorized 
through the chest wall. Closure then was routine. At the conclusion of the procedure, 
patients were returned to the supine position and reintubated with a single-lumen 
endotracheal tube for postoperative ventilation. Reduced blood use and decreased risk of 
LIMA or cardiac structural injury during sternal reentry make it a desirable approach for 
many complicated mitral reoperations. Deep hypothermia (~20°C) and low-flow femoro-
femoral bypass perfusion, without the necessity of aortic cross-clamping, provide 
adequate myocardial protection. Cardiopulmonary bypass times, blood loss, blood 
product usage, and LIMA injury rates have been lower in reoperative patients undergoing 
right thoracotomy than in those with resternotomy (5). 
Certain issues must be considered before the right thoracotomy approach is 
entertained. Patients who require simultaneous coronary artery bypass grafting generally 
will require a median sternotomy, although isolated right-sided grafting may be 
performed with a thoracotomy. Simultaneous replacement of the aortic valve is difficult 
from a thoracotomy approach and generally should be performed through a resternotomy. 
Significant aortic insufficiency can make effective perfusion on cardiopulmonary bypass 
difficult because, after opening the left atrium, blood will be returned to the pump via the 
cardiotomy suction. Unless the ascending aorta is clamped, effective end-organ perfusion 
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will not be achieved. Also, in the setting of aortic insufficiency (AI), exposure of the 
mitral valve may be difficult owing to this regurgitant flow into the surgical field. Left 
ventricular distension and myocardial stretch injury also can occur with fibrillatory arrest 
in patients with and occasionally without AI. Patients with greater than minimal aortic 
insufficiency therefore should either be excluded from a right thoracotomy approach or 
expected to require aortic cross-clamping either with traditional clamping or rarely with 
balloon occlusion. Significant right pleural disease, especially scarring in the right 
hemithorax, is a relative contraindication to a right thoracotomy.  
Left thoracotomy approach 
The left thoracotomy has been used in recent years to gain access to the mitral 
valve in situations in which a right thoracotomy is precluded (e.g., mastectomy/radiation 
or pleurodesis)(5). This incision is made through the fourth intercostal space, and the left 
pleural cavity is entered in the standard fashion. Surgery is performed under fibrillatory 
arrest or with beating-heart technique. Of importance, the mitral valve orientation is 
noted to be upside down with this approach, with the posterior annulus found anteriorly. 
While occasionally useful, this approach provides limited access to the other cardiac 
chambers as well as poor visibility. This left-sided approach is rarely needed and 
typically reserved for patients in whom reoperative sternotomy or right thoracotomy is 
considered unacceptable.  
Transverse  sternotomy 
A bilateral anterior thoracotomy (i.e., transverse sternotomy) carried out through 
the fourth intercostal space also has been described (5). Rarely used today, this incision 
transects the sternum transversely, requiring ligation of both internal mammary arteries. 
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Minimally invasive/port access right-sided techniques 
A final approach to the reoperative mitral/aortic valve is with minimally invasive 
or port access techniques. A large incision that increases the operative exposure also has 
been associated with a higher risk of injury to cardiac structures and coronary artery 
bypass grafts and results in greater bleeding with its associated transfusion requirements. 
A smaller incision with a limited sternotomy or anterolateral thoracotomy on the other 
hand, reduces the area of pericardiolysis, thus mitigating these effects. The intact lower 
sternum that remains also preserves the integrity of the caudal chest wall, thereby 
enhancing sternal stability and promoting earlier extubation. Minimally invasive valve 
procedures gradually have become more accepted as new technologies and 
instrumentation have been developed (5).  
CANNULATION 
Cannulation for bypass can either be peripheral or central the choice for 
cannulation depends on the risk of the case and the quality of the vasculature. The 
presence of multiple patent graft anastomoses to the aorta may favor peripheral arterial 
cannulation. In patients who are at high risk of catastrophic injury to mediastinal 
structures, arterial and in certain cases venous, cannulation may be carried out 
peripherally, prior to sternotomy. The axillary artery, which is readily accessed via a 5-to 
6-cm incision in the deltoid crease, offers less risk of limb ischemia and cerebrovascular 
events than the femoral artery, which is less well collateralized and produces much more 
extensive retrograde flow. The commonest complications of axillary artery cannulation 
involve trauma to the branches of the brachial plexus (5), which is closely involved with 
the artery. The femoral artery may be accessed either using a Seldinger technique or more 
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usually via a 3- to 4-cm incision in the inguinal skin crease, the femoral artery is more 
affected by atherosclerotic disease, and a careful check of distal pulses is mandatory after 
decannulation. Occasionally, the arteriotomy will need revision or patch repair to ensure 
distal flow. If arterial cannulation alone is carried out peripherally, it is not necessary to 
fully heparinize the patient initially (5) : Single dose of 5000 units of heparin together 
with asking the perfusionist to flush the arterial cannula every 10 – 15 minutes or so once 
it is connected will be sufficient to keep the line free of thrombus. Full heparinization to 
an activated clotting time of greater than 480 seconds is required prior to venous 
cannulation, use of pump suction, or institution of cardiopulmonary bypass. Cannulating 
via a side-graft reduces the risk of distal limb ischemia that comes with direct 
cannulation, but takes significantly longer and has been associated with distal hyper 
perfusion. If a side-graft is used a distal arterial catheter should be placed in addition to a 
contra lateral one to detect hyper perfusion intra-operatively. 
 The only indication to cannulate the peripheral veins prior to sternotomy, which 
mandates full heparinization, is if the surgeon anticipates very high risk of injury 
requiring bypass on sternal entry. The axillary vein may occasionally be used, but the 
femoral vein affords better access. Either a Seldinger technique or an open cut-down may 
be used, a wire inserted into the right atrium under transesophageal guidance, and the 
cannula advanced into the right atrium. The most serious immediate complication of 
femoral venous and arterial cannulation is retroperitoneal hemorrhage from perforation of 
the femoral or iliac vessels (19,20,21), which may not become apparent until late in the 
case when the perfusionist notices low flows and poor venous drainage, and the patient’s 
abdomen is already distended.  If a soft tipped wire is inserted without excessive force, 
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not forced against resistance and is kept under tension with free mobility backwards and 
forwards at all stages, then dissection and perforation are rare. 
CARDIOPULMONARY BYPASS  
Cardiopulmonary by pass can be initiated prior to or after the sternotomy as 
dictated by the risk. Many surgeons concerned about opening the sternum in the presence 
of adhesions advocate the use of femoral-vein-to-femoral-artery bypass before sternal 
reentry with the aim of decompression of the heart and increasing the distance between 
the mediastinal structures and the sternum. After moderate cooling, the heart is emptied. 
As it collapses and pulls away from the sternum, the bone can be opened with an 
oscillating saw without danger to the heart. Once sternotomy is complete, the patient may 
be weaned off bypass (14). On the other hand, if bleeding occurs a cardiotomy can be 
immediately inserted through the wound of the right ventricle or right atrium, while the 
aorta or the femoral arteries are cannulated in extremis, but this situation is very rare 
indeed. In high-risk situations, the femoral or iliac artery may be preventively cannulated. 
Generally, the most commonly used method is the right atrium to aorta cardiopulmonary 
bypass. A single- or double-stage cannula may be used for venous drainage, but two vena 
cava cannulae are used for mitral procedures. Although commencing bypass prior to 
sternotomy increases bypass time, it reduces the risk of injury and catastrophic bleeding 
and does not appear to increase morbidity or mortality. The disadvantage is that total 
bypass time is prolonged, and dissection is performed in a fully heparinized patient 
leading to increased transfusion requirements. In patients with aortic insufficiency, it may 
be necessary to place a left ventricular vent to prevent the heart from distending, which 
may be done in advance of instituting bypass through a small left anterior thoracotomy if 
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standard routes are not accessible. Transesophageal echocardiography should be used to 
monitor left ventricular distension. 
MYOCARDIAL PROTECTION 
 Myocardial protection in reoperations may be delivered in exactly the same way 
as in first-time surgery with several additional considerations relating to the longer 
operation times, poor myocardial function, and more advanced native disease associated 
with reoperative procedures: challenges in the placing of the cardioplegia catheters; and 
finally, the presence of patent bypass grafts that will wash out the cardioplegic solution 
from the myocardium throughout the case unless they can be occluded. The presence of 
proximal coronary bypass graft anastomoses on the ascending aorta may mean that 
finding a suitable place to locate an antegrade cardioplegia catheter could be challenging. 
Correct placement of a retrograde catheter cannot be assisted or confirmed by palpation if 
the diaphragmatic surface of the heart has not been dissected free, and the surgeon has to 
rely on transesophageal echocardiography. It is therefore important to ensure that the 
cannula is in adequate position while giving cardioplegia by monitoring the pressure in 
the coronary sinus or observing blood return from the left and right main coronary 
arteries if the aorta is open. 
 Retrograde cardioplegia offers the advantage of better distribution than ante grade 
cardioplegia to territories subtended by severely diseased native coronaries(18). If the 
patient has patent mammary artery bypass graft or the cross-clamp has been placed 
proximal to any patent aortocoronary graft, noncardioplegic blood flow will continually 
wash out cardioplegia throughout the case. There are several options in this setting. 
Traditional teaching was that the left anterior descending artery should be dissected out 
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and clamped or even occluded percutaneously using a ballon-tipped guide wire under 
fluoroscopic guidance. A useful alternative is to leave the patent grafts intact and perform 
the surgery with the patient cooled to about 25 C, which affords good myocardial 
protection because the heart is supplied with oxygenated blood continuously. The 
operative field will remain blood filled for the duration of the case, which can be dealt 
with by reducing the pump flow for very short periods of time when unimpaired vision is 
essential. A third option is to perform surgery without cardioplegic arrest, either off-
pump (for coronary artery surgery) or on by pass (for mitral valve surgery) with the heart 
beating and with intermittent fibrillatory arrest. The latter option is not feasible in the 
setting of more-than-mild aortic insufficiency. 
ACCESS TO CARDIAC CHAMBERS 
For access to an aortic prosthesis, the usual oblique or longitudinal incision of the 
aortic root should be used. By contrast, regardless of the actual approach, once 
cardiopulmonary bypass has been established and the heart exposed, there are several 
incisions that can be employed to view the underlying mitral valve, including that which 
is classically used for primary operations(5). The standard left atriotomy begins with 
blunt dissection of the interatrial groove (i.e., Waterston’s groove), allowing the right 
atrium to be retracted medially and anteriorly. The right superior pulmonary vein at its 
junction with the left atrium then is exposed, and the left atrium is opened at the midpoint 
between the right superior pulmonary vein insertion and the interatrial groove. This 
incision is extended longitudinally both superiorly and inferiorly to give enough exposure 
of the mitral valve. Care must be taken to avoid inadvertent injury to the posterior wall of 
the left atrium, and when closing, one must avoid including the posterior wall of the right 
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pulmonary vein an incision posterior to the interatrial groove and anterior to the right 
pulmonary veins. The exposure of the mitral valve given by this incision in reoperation is 
clearly more limited than that which it gives in the primary valve procedure, especially in 
small atria and where the adhesions of the left side of the heart have not been released. In 
some cases, wide opening of the left pleural cavity allows a leftward rotation of the heart 
and facilitates exposure. The superior approach, through the root of the left atrium, also 
provides excellent exposure, probably as good as in the first operation. A modification of 
the Dubost technique, which has recently been described by the Edinburgh group, starts 
with the classical approach. If there are difficulties in the visualization of the valve, a T-
incision through the right atria1 wall and the interatrial septum is carried out which gives 
a clearer view of the mitral valve. The right atrial transeptal approach has become more 
popular in recent years, especially in reoperative valve surgery. After opening the right 
atrium, the interatrial septum is incised starting at the fossa ovalis and moving vertically 
upward for a few centimeters. This technique is especially helpful in reoperative surgery 
because it minimizes the amount of dissection required. All these alternative approaches 
create additional difficulties, since the surgeon must first dissect and snare the superior 
and inferior venae cavae. Also, the integrity of the interatrial septum may be affected. 
Finally, a right anterolateral thoracotomy during femoro-femoral bypass without aortic 
cross-clamping or cardioplegia has been recommended, especially for multiple 
reoperations on the mitral valve. 
Removal of the prosthesis 
Retrieval of the abnormal prosthesis presents some technical difficulties. They 
can be removed with the whole valve intact or in two stages. Removal of the whole valve 
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intact is accomplished by cutting the sutures and dissecting the interface between the 
sewing ring and the tissues, leaving the annulus virtually ready for the new sutures and 
prosthesis. However, others suggest cutting through the sewing ring, removing first the 
body of the prosthesis, and retrieving the remains of the ring at a second stage. This may 
be simpler, but there is the risk of embolisation by particles left behind. 
All techniques must be tailored according to the circumstances. Importantly, 
however, utmost care must be exercised to preserve the integrity of the patient’s annulus, 
especially in the case of the mitral valve, where the atrioventricular junction may easily 
be disrupted with disastrous consequences (5). 
Finally, treatment of annular abscesses in the case of prosthetic valve endocarditis 
may be another very delicate technical problem. Bovine pericardial patches have been 
used to reconstruct the disrupted annular areas. Whenever possible, however, aortic root 
abscesses should be left open to the bloodstream to facilitate sterilization, and the 
prosthesis should be sutured either to the inferior or superior edge, whichever appears 
more convenient. Nevertheless, if the abscess threatens rupture into the pericardium, or in 
other very extensive annular destructions, homograft aortic root replacement may be the 
best option (3,5). Other composite grafts may also be used, but homografts are more 
resistant to reinfection. Transplantation has also been suggested in situations of 
uncontrolled infection accompanied by extensive destruction of cardiac tissues. 
ADDITIONAL TECHNIQUES OF REOPERATIVE MITRAL SURGERY 
A less common indication for reoperative mitral valve surgery but one that can be 
challenging is periprosthetic leak. The incidence of perivalvular leak for both mechanical 
and biologic valves is about 0 to 1.5% per patient-year(3). Of note, perivalvular leak is 
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slightly more common with mechanical than with tissue valves-possibly owing to 
differences in suture technique for each and sewing ring characteristics. The regurgitant 
flow across the perivalvular area frequently leads to hemolysis and, through denuding of 
the endocardium, endocarditis.  
In evaluating patients with a periprosthetic leak, an assessment of valve function 
is important. If the valve itself is competent, direct repair of the leak avoids the hazards of 
valve replacement. While pledgetted suturing may be attempted for smaller leaks, fibrotic 
tethering of surrounding tissue and the size of the defect may require a bovine or 
autologous pericardial patch. In cases of significant dehiscence or associated valvular 
dysfunction, removal of the valve is necessary. Replacement in this situation, however, is 
prone to leak recurrence because the annulus is partially intact, often calcified, and 
otherwise less than ideal for suture placement. In these cases, a bovine pericardial skirt 
can be fashioned and sewn to the sewing ring of the valve. Annular sutures then are 
placed in a typical fashion through the sewing ring, and the valve is seated. A running 
suture then can be used to sew this skirt to the left atrium. 
An additional risk of reoperative mitral valve replacement is atrioventricular 
disruption. Care must be used in removing the original valve sewing ring because it is 
frequently "socked in," and inadvertent removal of excessive annular tissue may occur. 
Any evidence of disruption of the posterior annulus necessitates patch repair with 
pericardium (autologous or bovine) prior to placement of annular sutures. When faced 
with less than ideal annular tissue, and in an attempt to ensure stability, bites must not be 
overly aggressive in depth. Left circumflex injury can occur and will lead to significant 
morbidity and mortality.  
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IMPLANTATION OF A NEW PROSTHESIS 
The choice of prosthesis for re-placement is sometimes very difficult. Is it correct 
to insert a mechanical valve when reoperating for a degenerated bioprosthesis in a young 
but noncompliant patient? Or to implant a biological valve in a similar patient reoperated 
on for a thrombosed mechanical prosthesis? The decision must consider the individual 
and collective characteristics of the patients and the surgeon’s experience with that 
particular population. Additionally, the pathology and the anatomy of the annulus may 
influence the decision. Bioprostheses, for example, conform better with annular 
irregularities and are allegedly more resistant to reinfection(5,6).  A continuous suture 
may be used for mitral valve reimplantation as for the first valve replacement if the 
annulus is still fairly regular after removal of the previous prosthesis. Most often, 
however, interrupted sutures must be used to ensure that the tissues hold, because the 
annulus is not as soft and pliable as in the initial procedure.  On the other hand, 
interrupted sutures are usually preferred for aortic valve implantation. The use of Teflon 
pledgets is not always warranted, but when necessary they should be placed on the atria1 
or on the aortic side. 
  WEANING FROM BYPASS 
 When de-airing the heart in reoperative surgery, particularly after mitral valve 
surgery, it is worth spending several extra minutes filling the heart and performing 
alveolar recruitment maneuvers while still on bypass because the pulmonary vasculature 
and left ventricle are splinted open by adhesions and tend to entrap much more air. 
Protamine should certainly not be given until several minutes after bypass is discontinued 
and most of the air appears to have been vented. If bypass is discontinued too rapidly, this 
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air is expelled once the heart starts ejecting, embolizing down the coronary arteries and 
any grafts, resulting in hemodynamic compromise that may be severe enough to require 
reinstitution of bypass. If Protamine has already been given, not only will reinstitution of 
bypass be delayed until the patient has been reheparinized, but the hemodynamic 
instability may be mistakenly attributed to a Protamine reaction and incorrectly treated as 
such. 
COAGULATION MANAGEMENT, POSTOPERATIVE HEMORRHAGE AND 
BLOOD SAVING 
 A systematic approach requires that hemostasis be carried out in exactly the same 
fashion used in first-time surgery. Because of large surface areas of dissection and, 
frequently, prolonged bypass times, reoperative patients may experience more profound 
coagulopathy after separation from bypass. For this reason, many clinicians have a lower 
threshold for stopping antiplatelet medication preoperatively in reoperative patients. 
Obtaining point-of-care testing with platelet function assays and thromboelastography is 
prudent(14), so that the dysfunction within the patient’s coagulation system can be 
specifically targeted and the risks of transfusion minimized. Antifibrinolytics, specifically 
aminocaproic acid (150 mg/kg bolus prior to skin incision followed by a continuous 
infusion of 25 mg/kg/h for the duration of the case) may be used if there is no 
contraindication, in all patient. 
Some aspects of the surgical technique may alter postoperative 
hemorrhage(13,14). These include limitation of the initial dissection of the pericardium to 
that essential for cannulation and access to the prosthesis. On the other hand, closure of 
the pericardium may not be possible, particularly if it had not been closed during the first 
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operation. Because multiple reoperations are often required it still is advantageous to 
close the pericardial sac. Bovine pericardium has been used as a pericardial substitute, 
although the results do not appear to be very favorable. The Gore-Tex membrane has 
apparently had better results. Closure of the pericardial space not only facilitates an 
eventual re-reoperation(14) but also helps prevent the accumulation of free blood and 
clots, itself a factor which tends to perpetuate hemorrhage. Substitution or 
pharmacological manipulation of the clotting factors is important in these patients who 
are often on anticoagulation therapy. Additionally, congestive cardiac failure frequently 
leads to hepatic failure which results in lower prothrombin activity. Aprotinin has been 
shown to reduce perioperative bleeding, and its use is optional during reoperations. The 
cardiotomy reservoir can used to collect the chest tube drainage; the reservoir is simply 
attached to the drains using the bypass circuit tubing. As a very inexpensive and 
unsophisticated method of reinfusion, a regular blood transfusion and filter are attached 
to the outlet of the reservoir and to one of the three-way tap bridges used during the 
operation. Blood is reinfused manually with a 50-ml syringe, which should never be 
detached from the system, to avoid infection. Alternatively, an automatic pumping 
system may be utilized(14).  
EMERGENCY SCENARIOS 
Intraoperative adverse events occurred in 7% of 1847 reoperative cardiac 
procedures in a recent analysis focusing on these outcomes(10). The adverse events were 
characterized on the basis of the structures injured, the timing of the event during surgery, 
and associated lapses in workup that may have contributed. Only 23% of complications 
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occurred during sternotomy(21); the majority of intraoperative adverse events occurred 
during the mediastinal dissection and before clamping.  
Catastrophic injuries on sternotomy include trauma to arterial structures-namely, 
patent bypass grafts (which are the most frequently injured structures) and the aorta and 
venous structures-namely, the right atrium, right ventricle, and in nominate vein. Injury to 
venous structures necessitates rapid volume replacement, which may be carried out via 
large peripheral or central venous lines but most optionally via an arterial bypass cannula. 
Venous structures are particularly at risk in patients with right heart failure. Injury to 
arterial structures is immediately life threatening, either from hemorrhage or from 
myocardial ischemia, and usually mandates emergency cannulation and institution of 
bypass.  
If injury that results in life-threatenting bleeding occurs as a result of sternotomy 
but before the patients has been cannulated, the anesthesiologist should give a full dose of 
heparin immediately while the surgeon reapproximates the sternum using towel clips or 
an assistant in a temporizing measure to take any tension off the injured structure and 
tamponade bleeding (13,14). Extra thoracic sites should then be cannulated emergently 
and bypass initiated prior to attempted repair, and the patient cooled. Once fully 
heparinized, it is possible to go on “suction bypass” as soon as arterial cannulation is 
secured, with all venous return coming from the pump suckers placed in proximity to the 
site of hemorrhage, until venous cannulation can be established. During this time, the 
anesthesiologist and perfusionist must work closely to maintain adequate perfusion of 
both brain and heart. In the case of a major injury to the aorta, this is rarely possible, and 
the dire outcomes reflect this.  
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The onset of ventricular fibrillation associated with arterial bleeding on 
sternotomy or mediastinal dissection in this context can only be treated by instituting 
cardiopulmonary bypass and ensuring that the left ventricle is decompressed, followed by 
repair of the laceration. 
The occurrence of a major intraoperative adverse event is associated with a 
moderately increased postoperative mortality and morbidity. It also affects intraoperative 
decision making. The surgeon may elect not to address lesions with borderline 
indications to reduce subsequent bypass and ischemic time, and not infrequently, it is 
necessary to defer chest closure to another day. 
TECHNICAL PROGRESS IN RE-OPERATIVE VALVE SURGERY 
Several improvements have been implemented over the last quarter of century. 
Some are related to technological evolutions, others to increased surgical experience (14). 
1, Femoro-femoral Extra Corporeal circulation before sternotomy is done if the 
cardiosternal contact is important on lateral chest x-ray. Thin walled venous tubing 
development has considerably improved venous drainage in femorofemoral bypass. If 
required, active venous suction using a centrifugal pump may be helpful. 
2, Redo sternotomy uses an oscillating saw to limit the risk of tearing underlying 
structures (innominate vein, ascending aorta, right atrium and right ventricle).   
3, Defibrillation patches directly applied on to the patient’s skin allow rapid 
external electric shock administration if the patient starts fibrillating during the early 
stages of the operation. Use of electro-cautery sometimes induces ventricular fibrillation. 
Defibrillation should be ensured in this situation as quickly as possible. Cardio-
pericardial adhesions could impair the possibilities to internally defibrillate the heart. 
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External defibrillation should be used in such a situation. Another lifesaving procedure is 
the rapid opening of both pleural spaces and transpleural internal defibrillation.   
4, Primary extensive cardio-pericardial adhesions liberation had been reported to 
facilitate mobilization and evacuation of intra-cardiac air and to make the intra-cardiac 
procedure easier and safer. Adhesiotomy using electro-cautery limits bleeding. This 
strategy is weighed against limited dissection as for isolated aortic valve replacement in 
redo patients.  
5, Thoracotomy surgery: Atrio-ventricular valve surgery can be done through an 
antero-lateral thoracotomy as first reported in the late 80s (5). Stratagems used were 
femorofemoral bypass, profound hypothermia and low flow perfusion without aortic 
cross clamping or cardioplegia.  
The indications for this strategy are  previous mediastinitis, severe right ventricle 
and pulmonary hypertension with previous multiple sternotomies, intact coronary arteries 
bypass grafts (especially mammary pedicles) and previous aortic valve replacement 
(especially with high profile prostheses) without any new aortic valve indication for 
surgery 
6, Mitral exposure during re-intervention can be hazardous. Cardio-pericardial 
adhesiotomy can be difficult and time consuming in some circumstances. Precocious left 
mediastinal pleurotomy through median sternotomy achieved ventricular mobilisation 
and improved exposure of the mitral valve(14). Moreover, this simple, safe and time-
saving technique, if realized before sternal retraction, allows the avoidance of shear-stress 
on medial structures, such as the innominate vein, the right atrium and ventricle and the 
aorta. Right pleurotomy also serves the same purpose. 
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7, Improved ECC technology, particularly biocompatibility, have reduced the 
systemic inflammatory response syndrome. Systemic hypothermia, low flow and 
circulatory arrest can all help in the management of delicate redo-related technical 
difficulties.   
8, Improved myocardial protection technique: Hypertrophied hearts, frequently 
found in heart valve disease, make myocardial protection critical. Antegrade cardioplegia 
associated with topical cooling of the heart can be impaired in redo valve surgery. Aortic 
regurgitation limits the efficacy of antegrade cardioplegia (unless given directly into the 
coronary ostia) and extensive adhesions oppose adequate topical cooling. Although 
retrograde cardioplegia efficiency had been challenged, especially in hypertrophied 
myocardium, it has been widely used in both valve and coronary surgery with success. 
Despite less complete right ventricle protection, retrograde cardioplegia is a safe 
alternative in conditions where myocardial protection is inadequate in valve surgery with 
aortic insufficiency.  
9, Improved intensive care management may also have contributed to the general 
amelioration of the results. During the last 30 years, mechanical and pharmacological 
support of the failing heart has progressed greatly. Monitoring with the Swan Ganz 
catheter allows precise hemodynamic evaluation nowadays at the cost of an very rare 
catastrophic pulmonary hemorrhage.  
10, The Cell Saver has proved useful in redo cardiac surgery patients, even if its 
efficacy in reducing transfusion requirements for redo valvular patients remains 
questionable. 
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10, Aprotinin: Peri-operative blood loss and blood transfusion requirements were 
reduced by Aprotinin use in primary cardiac surgery under bypass(10,14,23). This benefit 
should also improve blood loss during redo surgery. Hypersensitivity to Aprotinin should 
be tested in cases of recurrent administration of this drug. 
 Experience in redo valve surgery should influence first operation strategies. 
Large pericardial windows have previously been used by some to prevent cardiac 
tamponade, a benefit still awaiting demonstration. Experience in redo surgery should 
absolutely negate the usefulness of such practice. Eighty-eight percent of the 
hemorrhages during re-entry in redo cardiac surgery occur in situations in which the 
pericardium had not been closed in a first operation. Meticulous hemostasis during the 
first operation considerably limits the formation of adhesions. Hence some surgeons 
produce safer redo candidates than others. 
RISK FACTORS IN REDO VALVE SURGERY  
 The experience acquired during the last 20 years in heart valve re-operations is 
considerable. Various prognostic factors influencing outcome after redo valve surgery 
have been identified(6,9,10,13,14,23). 
1, NYHA functional class: The most frequently quoted risk factor associated with death 
in redo valve surgery is the New York Heart Association (NYHA) functional class. 
Mortality up to 30% has been associated with stage IV compared to less than 10% in 
stage II and III. One of the first reports of redo valve surgery clearly suggests that when 
significant valve dysfunction is first noted, re-operation should be undertaken to 
minimize operative risk. Later observations generally emphasized this recommendation. 
This is particularly true in patients who benefit from a bioprosthesis in the mitral 
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position. The most common cause of re-replacement of a prosthetic valve is bioprosthesis 
degeneration. Structural valve degeneration of a bioprosthesis generally appears after 8 
years of follow-up, especially in young patients and in the mitral position. Early re-
operation before irreversible deterioration occurs is advised, since myocardial function 
was found to be a major determinant of surgical results. 
2, Surgical priority: The second most frequently reported risk factor is the degree of 
urgency in the re-operation of patients. The reported mortality risk of elective re-
operation is as low as 5.4% to 11%, while, for emergency procedures, it could be as high 
as 38 to 61.5%.  
3, Valve position: The influence of the valve position as a risk factor is controversial. 
Some data suggest that redo mitral surgery increases risks (19.6%) compared to aortic 
(5.9%). Another series reports the contrary, that mitral valve re-operation carries a 12% 
risk versus 26% in the aortic position. The valve position was recently found not to be a 
determinant risk factor. Double valve replacement compared to single, represents a 
significant risk factor : mortality increases from 3.2% in single to 25.0% in double valve 
recipients. 
4, Number of previous operations: The number of previous operations has been 
reported as a risk factor. Hospital mortality had been reported as high as 21.7% for the 
second, 20% for the third and 55.6% for the fourth re-operations.  
5, Tricuspid valve surgery requirement (replacement or annuloplasty) is associated with 
a higher mortality than the same operation without tricuspidal disease, probably reflecting 
more advanced disease and higher pulmonary artery pressures. Pre-operative morbid 
process bears a significant correlation with mortality. 
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6, Prosthetic valve endocarditis has been associated with a postoperative mortality of 
up to 50%(15,23). 
7, Mechanical valve thrombosis also carries an important risk (43%) of death compared 
to structural deterioration of bioprostheses (9%)(15,23). 
 8, Associated coronary artery lesions and associated CABG requirements present a 
higher operative mortality.  
9, Gender has been identified as a risk factor, female having been recently reported to 
present a higher operative mortality compared to male. Risk associated to gender, 
contradicted in the past in this particular surgery, is currently accepted as a general risk 
factor in cardiac surgery today(6,13,15,23). 
10, Renal impairment was higher in non-survivors compared to survivors(6,9,15,23).  
11, Operation time, aortic cross clamp time  and pump run are reported  to have been 
significantly longer in patients who died(6,9,12,15,16,23). 
13, The type of prosthesis implanted originally seems not to influence patient outcome 
after heart valve re-operation. However, failing mechanical prostheses are associated with 
a higher mortality (21%) than bioprosthesis degeneration (a more progressive event: 
10%).  
14, The era of operation had been reported as a risk factor of mortality(15,17,23) . As 
previously mentioned, studies concerning patients operated on between 1980 and 1992 
clearly exhibited a decreased mortality through the years. Cohn reported that mortality 
for re-replacement fell, between 1980 and 1992, in aortic valve from 15% to 10%, in 
double valve from 20% to 9%, and in mitral valve from 16% to 6% (2). Such 
improvements in mortality have been confirmed in other studies. 
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The age of the patients ranged from 12 to 69 years with the mean age at the time 
of operation being 42.97 ± 14.53 years. There were 27 males and 16 female patients (M/F 
ratio = 1.68:1). 23 (53.5%) were older than 40 years of age. 32 patients (74.41%) had 
Rheumatic heart disease with only 10 patients (31.25%) still continuing Penicillin 
prophylaxis. 
 Of the total 43 patients, 17 patients (39.54 %) presented with NYHA class II 
symptoms, 19 patients (44.18 %) with NYHA class III and 7 patients (16.27 %) presented 
with NYHA class IV symptoms. Dyspnoea on exertion was the most common presenting 
symptom (86%). 
 24 patients (55.81%) were in atrial fibrillation with the rest being in sinus rhythm. 
Congestive cardiac failure was present in 9 (20.9%) patients. A history of neurological 
deficits was present in 3(6.9%) patients. 5 patients (11.62%) had history of infective 
endocarditis detected by blood culture or echocardiography. Renal dysfunction was 
present in 6(13.95%) patients. 
 The 43 patients formed a heterogeneous group in terms of the first open heart 
procedure they underwent. 15 (34.88%) patients underwent Aortic valve replacement. 
12(27.9%) patients underwent Mitral valve replacement. 5 (11.62%) patients underwent 
open mitral valvotomy/valve repairs. 2 (4.65%) patients underwent double valve 
replacement( 1 underwent a aortic and mitral valve replacement and another underwent a 
mitral and tricuspid valve replacement). 9 (20.93%) patients underwent intracardiac 
repair for congenital heart disease (including ASD, VSD closure, intracardiac repair for 
TOF, DORV). 
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 30 (69.76%) had rheumatic heart disease at time of first operation and 4 (9.3%) 
had valve replacements for other etiologies like bicuspid aortic valve, degenerative aortic 
valve disease. Among the 9 patients who underwent surgery for congenital heart disease, 
2 patients subsequently developed Rheumatic heart disease. 
 Echocardiography revealed 19 (44.18%) patients with normal left ventricular 
ejection fraction and an equal number with an ejection fraction between 35% and 55% 
(mild to moderate LV dysfunction). 5 (11.62%) patients had an ejection fraction less than 
35% (severe LV dysfunction). 
 The average interval to reoperation was 12.3 ± 7.08 years with a range of 1 – 29 
years. The duration of implantation after the first operation was longest when 
malfunction was due to primary valvular failure (progression of native valve disease).The 
shortest intervals were those associated with malfunction due to endocarditis and 
occurrence of paravalvular leak. 35(81.39%) patients underwent an elective operation and 
the 8(18.6%) underwent the operation as an emergency. The indications for emergency 
surgery were prosthetic valve thrombosis (2), CCF with severe paravalvular leak (2 ), 
native valve endocarditis (1) and prosthetic valve endocarditis (1).  
 The indications for reoperation were progressive native valve disease in 27 
(62.79%) patients, Structural prosthetic valvular deterioration in 7 (16.27%) patients, Non 
structural dysfunction in 6(13.95%) patients, Prosthetic valve thrombosis in 2 (4.65%) 
patients and operated valvular endocarditis in 1 (2.32%) patient. The first reoperation was 
a Mitral valve replacement in 19(44.18%) patients, Aortic valve replacement in 
18(41.86%) patients, Double valve replacement (aortic and mitral) in 4 (9.30%) patients 
and Tricuspid valve replacement in 2 (4.65%) patients.  
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In the mitral position, Starr-Edwards mechanical valves were the   valve of choice 
though, the last year of study saw a shift to St.Jude Medical mechanical valves. In the 
aortic position, the Medtronic Hall mechanical valve was the valve of choice. In the 
tricuspid position, biological valves were utilized. 
20 (46.51%) patients had a cardiopulmonary bypass time less than 120 min and 
23 (54.48%) patients had a cardiopulmonary bypass time greater than 120 min. 36 
(83.72%) patients had aortic cross clamp times less than 60 min and 7 (16.27%) patients 
had aortic cross clamp times greater than 60 min. The mean cardiopulmonary bypass time 
was 123.90 ± 25.14 min and the mean aortic cross clamp time was 49.46 ± 12.81 min. 
No major incident of great vessel injury occurred in any of the cases. However 
minor injuries requiring control of bleeding with pledgetted prolene sutures were required 
in 11 patients. The minor injuries occurred in during course of the dissection to free the 
heart from the adhesions. The injuries were on the distended tense right atrium in 6 of the 
cases and minor right ventricular myocardial injuries in 5 of the cases. None of these 
injuries contributed to postoperative bleeding and was not the etiology in those cases 
which were returned for re-exploration. 
Major adverse postoperative events 
Operative mortality  
Over a 10-year period, from January 2000 until December 2009, 43 patients (27 
men and 16 women) with a mean age of 42.97 years (range 12-69 years) underwent first 
reoperation for a heart valve with an overall operative mortality(defined as death within 
30 days of operation regardless of the patient's geographic location) of 11.62% (n=5). 
Mortality was 4/27 (14.81%) for men and 1 of 16 (6.25%) for women; P= 0.635. The 
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mean age of those patients who had an operative death was 39.0 years (standard deviation 
[SD] 17.07) compared with 43.5 years (SD 13.88) for those who survived surgery (P = 
0.65). Of the 5 patients who had a operative mortality, 3 had an aortic valve replacement, 
1 had double valve replacements and one had a mitral valve replacement. 
 The causes of operative mortality were low cardiac output in 2 patients 
and refractory arrhythmia in 1 patient. The non cardiac causes were septicemia in 2 
patients. There was no other early mortality (defined as all-cause mortality at 30, 60, or 
90 days). 
Postoperative complications 
 Reexploration was required for postoperative bleeding in 3 (6.97%) patients. 
Rhythm abnormalities (fast atrial fibrillation, ventricular arrhythmias and variable 
degrees of AV block) were noted in 31(72.09%) patients. A single patient required 
permanent pacemaker implantation; however this patient was one of the hospital 
mortalities. Duration of postoperative inotropic support greater than 48 hours was 
required in 11(25.58%) patients. Pulmonary complications occurred in 8(18.60%) 
patients. Readmission to the ICU was required in 8(18.60%) patients. Septicemia 
occurred in 7(16.27%) patients. Major sternal infections and mediastinitis were seen in 
3(6.97%) patients. Minor wound infections were seen in 8(18.60%) patients. New onset 
postoperative renal dysfunction was noticed in 6(16.21%) patients, all of whom 
recovered with conservative management. Dialysis was required in only 1 patient (this 
patient had preoperative renal dysfunction). New onset neurological dysfunction was 
noticed in 3(6.97%) patients. Pericardial effusion was noticed in 8 (18.60%) patients and 
only 2 patients required pericardiostomy for evacuation of the effusion. There were less 
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common complications like hepatic dysfunction (n=1) and gastrointestinal bleeding (n=2) 
There were no vascular complications related to the femoral vessels secondary to the 
cannulation for vascular access.  
 Duration of ICU stay was less than 72 hours in 29 (69.44%) patients and greater 
than 72 hours in the rest (32.55%). The average duration of hospital stay was 13.34 days. 
 
Table 3:  Mortality according to principal valve procedure at reoperation 
Principal procedure Mortality Percentage 
Mitral valve replacement 1/19 5.2% 
Aortic valve replacement 2/18 11.1% 
Double valve replacement 2/4 50% 
Tricuspid valve replacement 0/2 0 
 
 
Surgical Priority (n- 43)
19%
81%
Elective
Emergency
 
Fig 5: Priority of reoperation 
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Fig 6: Indications for reoperation 
  
Causes of Operative mortality (n=5)
Low CO, 1
Hemorrahge, 1
Sepsis, 2
Refractory 
arrhythmias, 1
 
Fig 7: Causes of operative mortality 
 
 
 
 
Indications for reoperation (n=43)
5%2%
63%
14%
16%
Structural valve deterioration
Nonstructural dysfunction
Valve thrombosis
Operated valvular
endocarditis
Progressive Native valve
disease
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NYHA Status at last follow-up(n= 28)
I
54%
II
39%
III
7%
IV-0
 
Fig 8 : NYHA status at last follow-up 
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Fig 9: Follow-up Morbidity and mortality data 
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Table 4:   Operative details and in-hospital outcome 
Perioperative details 
              Surgical priority 
Elective 
     Emergency 
              Preoperative inotropes 
             Congestive cardiac failure 
 
                 
                      35(81.39%) 
                       8(18.6%) 
                       3(6.9%) 
                       9(20.93%) 
 Operative details          
             Cross clamp time (min) 
             Cardiopulmonary bypass time(min) 
          
 
                      49.46 ± 12.81 (IQR 42-53) 
                      123.90 ± 25.14(IQR 106-141) 
Nonfatal postoperative complications 
after re-operation 
Re-operation for bleeding 
              Pericardial effusion 
              Rhythm abnormalities 
              Septicemia 
              Pulmonary complications 
             Major sternal wounds/mediastinitis 
             Minor wound infections 
             Renal dysfunction 
             Neurological dysfunction 
   Inotropic support > 48 hours 
             Readmission to ICU 
 
 
 
                      3(6.97%) 
                      8(18.60%) 
                      31(72.09%) 
                       7(16.27%) 
                       8(18.60%) 
                       3(6.97%) 
                       8(18.60%) 
                       6(16.21%) 
                       3(6.97%) 
                       11(25.58%) 
                        8(18.60%) 
Outcome measure 
             30-day mortality  
             ICU stay(h) 
             Hospital stay(days) 
         
 
                        5 (11.62%) 
                        102 (IQR 48-96) 
                        13 (IQR 10-16) 
IQR: Interquartile range 
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LATE OUTCOME 
 The follow-up ranged from 3 months to ten years with a mean follow-up period of 
30.45 ± 31.26 months.  The total cumulative follow-up period was 944 patient years. The 
follow-up was 81.57% complete. There were 3 late deaths (9.37%).Congestive cardiac 
failure was the cause of death in 2 patients and the reason was unknown in 1 patient.  
Functional class: 
At the time of last follow-up, the NYHA functional classes of the 29 survivors 
were as follows: 53.57% patients were in class I, 39.28% in class II and 7.14% in class 
III. The noticed trend was that of those patients who were in class IV at time of 
reoperation were in class II/III while patients who had been in class III at time of the 
reoperation were in class I/II. 
Anticoagulation related hemorrhage: 
 Nonfatal major bleeding events requiring treatment occurred in four patients for a 
rate of 0.12 per 100 patient years. Another six patients had minor bleeding events not 
needing medical attention. 
Thromboembolic episodes: 
 Three patients had thromboembolic episodes with mild residual neurologic 
deficits for a linearized rate of 0.1 per 100 patient years. 
Prosthetic valve endocarditis: 
Two patients (0.06 per 100 patient years) developed infective endocarditis which 
was successfully managed with appropriate antibiotics. 
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STATISTICAL ANALYSIS: 
 Chi-Square test was done to assess the association between operative outcome  
(those who survived the operation and those who did not survive the operation) and risk 
factors namely; age, sex of patient, Preoperative NYHA class, surgical priority, presence 
of infective endocarditis, preoperative renal dysfunction, Presence of CCF, preoperative 
LV function, previous surgery, present indication for reoperation, present surgery, 
requirement of preoperative inotropes, total cross clamp time and total CPB time.  
The following variables were significant at 5% level: Preoperative NYHA class, surgical 
priority, presence of infective endocarditis, preoperative renal dysfunction, Presence of 
CCF, preoperative LV function, previous surgery, present indication for reoperation and 
total CPB time. 
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Table 5: Univariate analysis of mortality by risk factors for valvular reoperation 
Variable 
Survival status 
P value 
30 day operative 
mortality Survivors 
Age 
             <=40 years 
              >40 Years 
 
3(60) 
2(40) 
 
17(44.7) 
21(55.3) 
 
0.65 
Gender 
               Male 
               Female 
 
4(80) 
1(20) 
 
23(60.5) 
15(39.5) 
 
0.635 
NYHA Class 
               I 
               II 
               III 
               IV 
 
- 
- 
1(20) 
4(80) 
 
- 
17(44.7) 
18(47.4) 
3(7.9) 
0.001* 
 
Surgical type 
              Elective 
              Emergency 
 
2(40) 
3(60) 
 
33(86.8) 
5(13.2) 
 
0.037* 
Previous Surgery 
Valve repair/Valvotomy                     
Mitral valve replacement 
               Aortic  valve replacement 
               Double valve replacement 
               Intracardiac repair 
 
- 
1(20) 
- 
2(40) 
2(40) 
 
5(13.2) 
11(28.9) 
15(39.5) 
- 
7(18.4) 
0.003* 
LV function 
             >55% 
             35-55% 
             <35% 
 
1(20) 
- 
4(80) 
 
18(47.4) 
19(50) 
1(2.6) 
 
<0.001** 
Prior Bacterial Endocarditis 
             Present 
             Absent 
 
3(60) 
2(40) 
 
2(5.3) 
36(94.7) 
 
0.008* 
Indication for reoperation: 
              Structural deterioration 
              Nonstructural deterioration 
              Valve thrombosis 
              Operated valvular endocarditis 
              Progressive native valve disease 
- 
1(20) 
1(20) 
1(20) 
2(40) 
 
7(18.4) 
5(13.2) 
1(2.6) 
- 
25(65.8) 
0.040* 
Renal dysfunction 
            Present 
            Absent 
 
5(100) 
- 
 
1(2.6) 
37(97.4) 
<0.001** 
Preop Inotrope 
            Yes 
            No 
 
3(60) 
2 (40) 
 
- 
38(100) 
0.551 
CCF 
           Yes 
           No 
 
5(100) 
- 
 
4(10.5) 
34(89.5) 
<0.001** 
Cardiac pathology 
           RHD 
           Congenital heart disease 
            Others 
 
2(40.0) 
3(60.0) 
- 
 
27(71.1) 
7(18.4) 
4(10.5) 
0.133 
 
Type of Surgery 
           MVR 
           AVR 
           DVR 
           TVR 
 
1(20.0) 
3(60.0) 
1(20.0) 
- 
 
18(47.4) 
15(39.5) 
3(7.9) 
2(5.3) 
0.447 
Clamp time 59 ± 15.11 
 
48.13 ± 2.08 
 
0.059 
CBP time 152.60 ± 26.36 
 
120 ± 22.74 
 
0.005* 
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When bivariate analysis was performed using logistic regression, priority of 
operation and prior historyof a bacterial endocarditis or an active infection at time of 
surgery were significant contribution risk factors for hospital mortality.  
Table 6: Logistic regression analysis of incremental risk factors for hospital 
mortality 
 
Risk factor 
 
Odds ratio CI(95%) P value 
Surgical priority 
                     Elective 
Emergency 
 
Prior bacterial endocarditis 
                     Present 
                    Absent 
 
1 
0.10 
 
 
 
0.037 
1 
 
- 
0.013-0.76 
 
 
0.004-0.365 
- 
 
 
0.026* 
 
 
0.005* 
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Discussion  
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Cardiac reoperations represent one of the main challenges of cardiac surgery. The 
number of patients undergoing reoperation for valvular heart disease is increasing and 
will continue to increase as the general population ages. Rheumatic valvular heart disease 
will continue to be a health problem for the next few decades in the developing countries. 
In addition to this, the initial cardiac operations have begun to be performed at an earlier 
age, and the life expectancy is increasing due to this. Improved management of non 
prosthesis related complications has led to this occurrence. All these factors will 
contribute to a higher frequency of redo operations in the future. However the operative 
risk for reoperations is no longer substantially higher than the primary operation and the 
reoperation itself is no longer a risk factor for a poor outcome and we believe that cardiac 
reoperations may be done effectively and with acceptable risks when specific 
multidisciplinary approaches are adopted. Mortality at heart valve reoperations is higher 
than at primary valve procedures. However, patients undergoing heart valve reoperations 
are a heterogeneous group. Patients differ in terms of their initial valve operation, as well 
as in factors relating to the reoperation. 
This retrospective study includes 43 patients collected between January 2000 and 
December 2009. We retrospectively analyzed in-hospital data from January 1 2000 to 
December 31 2009, in these 43 patients. All patients had previous open heart surgeries 
for various etiologies, the bulk of them being valve replacement for Rheumatic valvular 
disease and needed a new valve operation. Indications for reoperation included native 
valve defect and mechanical valve complications. All were first redo valvular surgery for 
an isolated valvular disease. The present study aims at identifying the risk factors for 
operative mortality (major adverse postoperative event) and also the incidences of major 
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postoperative morbidity after cardiac reoperation, and thereby enables a fairly 
comprehensive evaluation of the risk of reoperation. 
The observed mortality in this population was 11.62 %, which compares 
favorably with the results published by Cohn (4) (10.1%), Pansini(22) (9.6%), 
Tekumit(21)(4.2%). This mortality rate was found to be 37.5% for emergency cases and 
5.7% for elective cases. Of these, two had an aortic valve replacement, two had double 
valve replacements and one had a mitral valve replacement. The cause of perioperative 
death was cardiovascular in 60% of cases in this cohort of patients undergoing 
reoperation. This cardiovascular morbidity resulted from especially myocardial failure 
reflecting the severely compromised hemodynamic conditions of the patients undergoing 
heart valve reoperations.  These results illustrate considerable improvement related to 
surgical experience and technical progress.  
The main factor making cardiac operations different and unique is the need for a 
sternotomy. Cardiac surgery requiring a re-sternotomy ( hence called “redo” surgery) is 
technically difficult and carries a higher operative risk than the initial operation.[4] The  
pericardium may or may not be closed after a heart surgery depending upon the surgeon’s 
preferences, and injuries to the right atrium and ventricle,  pulmonary artery, aorta and 
the innominate vein may occur during resternotomy.[5] Patients with valvular heart 
disease may be particularly prone to these complications, because right atrial dilatation 
can result in significant cardiomegaly, atrial thinning and adherence of the heart to the 
posterior sternum. 
 The incidence of catastrophic hemorrhage following a re-sternotomy is estimated 
at 0.5% - 1% (20). Follis et al (20) reported the results of 610 re-sternotomy cases in 
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which 10 (0.6 %) had an injury during the re-sternotomy and the initial dissection. The 
right ventricle was the second most commonly injured structure (21.4%). Injuries 
occurring during the reoperation have caused mortality rates as high as 21%.  
In our study group, there were no cases of major cardiac injury/hemorrhage 
following the sternal re-entry. This result is due to the fact that in our institute, the 
protocol for re-do cases is the routine use of femoro-femoral bypass before re-sternotomy 
thus decompressing the cardiac chambers.  There was also no instance of any major 
hemorrhage during adhesiolysis. Small myocardial injuries which occurred during 
adhesiolysis were tackled with pledgetted prolene sutures. Consideration should be given 
to the fact that the adhesions were noticed to become less inflammatory and less 
vascularized over time. Therefore, the longer the interval between the operations is, lesser 
the chances of injuries during resternotomy and adhesiolysis. Reoperation following a 
period six months to one year after the last operation are probably the most difficult 
surgeries.[10] In our study, the mean interval from the first operation to the reoperation 
was 12.3 ± 7.08 years(range  1 – 29 years).  
In valvular reoperations, the following factors were analyzed as being significant 
predictors of mortality: age, sex of patient, Preoperative NYHA class, surgical priority, 
presence of infective endocarditis, preoperative renal dysfunction, Presence of CCF, 
preoperative LV function, previous surgery, present indication for reoperation, present 
surgery, requirement of preoperative inotropes, total cross clamp time and total CPB 
time. 
 By univariate analysis the following factors were determined to contribute to 
operative mortality:  Preoperative NYHA class, surgical priority, presence of infective 
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endocarditis, preoperative renal dysfunction, Presence of CCF, preoperative LV function, 
previous surgery, present indication for reoperation and total CPB time. By multivariate 
analysis, only two factors were significant: surgical priority and the presence of infective 
endocarditis. 
 Some studies have shown that age is a factor in death after cardiac surgery, 
whereas another study disputes this conclusion. Age was not a significant factor in our 
study. Gender had no effect on the outcome, an observation that agrees with conclusions 
of Cohn et al (15) and Brandao et al (16). However, a study by Wauthy et al (7) showed 
evidence that female sex influenced death after cardiac surgeries.  
Preoperative functional class was identified as an important determinant of early 
mortality in this study ( P value < 0.001) and is a consistent finding in other series. 
Mortality for NYHA class IV patients was approximately 57%.This is in comparison 
with the approximately 5% mortality for class III patients and nil mortality for class II 
patients. Severe left ventricular dysfunction was probably responsible for the mortality 
that is associated with reoperation these patients. Cohn and associates also reported 
higher in patients with NYHA class III-IV. In our study, multivariable analysis failed to 
show the importance of NYHA functional class as an risk factor and this does not agree 
with most other studies. This probably is due to a limitation of this study, namely the 
small number of patients.  
Univariate analysis revealed LVEF (p value < 0.001) and presence of CCF (p 
value < 0.001) as significant factors contributing towards operative mortality. 
Emergency surgery was one of the most important factors determining reoperative 
outcome (OR- 0.1, 95%CI-0.013-0.76,p value=0.026) and the operative mortality for this 
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cohort in our study was 37.5 %. Other studies(7,9,18) also validate these findings. In this 
study, we had 18 % of patients undergoing reoperation on a emergency basis. These 
patients also presented with pronounced cardiac failure and secondary organ 
manifestations due to low cardiac output. This, in our view emphasizes the importance of 
minimizing the number of patients requiring emergency surgery reoperation and the most 
rational approach to this problem is prevention, ie early recognition and referral for 
surgery before severe ventricular decompensation has established and this  suggestion 
appears logical as is evidenced by the above results. This view is endorsed by Vogt et al 
(9) in his study of reoperative aortic valve reoperation.   
The influence of valve position as a risk factor is controversial. In our study, this 
factor was found not to be a determinant risk factor (P-value 0.447). Other series report 
contrary results with the aortic position being significant in some and mitral position 
being significant in others (7).  
Univariate analysis showed the type of initial surgery (P-value 0.003) and the 
present indication for operation (0.040) to be significant. However multivariate analysis 
failed to show any significance. The risk at reoperation for those patients who had an 
initial reparative procedure or those who were undergoing surgery for new native valve 
disease was extremely low. In this cohort of patients, we had no operative deaths. 
However, both patients who underwent double valve replacement as the initial procedure 
experienced operative mortality during reoperation. Such patients were probably not as 
severely compromised as those requiring surgery on a prosthetic valve. Expectedly, the 
extent of surgical dissection within the heart would have been less in those who did not 
require explantation of a previously inserted prosthetic valve.  Such a view is endorsed by 
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Wauthy et al (7) also who had a low operative mortality (3%) for patients undergoing 
reoperations after an initial reparative procedure or those who were undergoing surgery 
for new native valve disease. 
Infective endocarditis (native or prosthetic valve endocarditis was one of the most 
significant factors identified in this study (OR-0.037, 95%CI- 0.004-0.365, p=0.005) and 
other studies (18) as a determinant of early mortality following reoperative valve surgery. 
Patients with endocarditis are a heterogenous group, many of whom have severe 
hemodynamic compromise and associated illness. It is therefore intuitive that many of 
these patients would be at high risk of reoperative surgery, which is often performed on 
an emergency basis which itself constitutes on of the foremost contributing risk factor for 
reoperation. 
 The presence of preoperative renal insufficiency was a predictor of hospital 
mortality by Univariate analysis (p < 0.001). Potter et al (10) and Pansini et al (22) 
identified renal insufficiency as an independent predictor of morbidity and mortality in 
patients submitted for valvular reoperations.  
Cardiopulmonary bypass time was found to be a significant factor at univariate 
analysis (P -0.005). However Aortic cross clamp time was not a significant factor (P-
0.059). Longer CPB times were associated with other factors such as lengthy operations, 
multivalvular procedures, or patients with ventricular dysfunction that needed prolonged 
circulatory assistance. This factor was reported as significant by Brandao et al (16) and 
Jones et al (10) too. 
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Early morbidity 
Re-exploration for bleeding was required in 3 patients and rhythm abnormalities 
were noted in a majority of patients (atrial fibrillation was most common) and these very 
well controlled with medications. Patients who required a greater period of postoperative 
inotropic support were expectedly those patients who had low preoperative low ejection 
fractions. The most important cause of morbidity in survivors is pulmonary complications 
and these in return contributed to readmission to the ICU. Septicemia occurred in 16.27% 
patients and only one of these patients accounted for an operative mortality. Aggressive 
medical management is required for those patients who develop sepsis as is evidenced by 
this study. Major sternal infections and mediastinitis were seen in 3 patients. This also 
requires aggressive management and intervention through debridement and resuturing. 
New onset postoperative renal dysfunction was noticed in a few patients, all of whom 
recovered with conservative management. Dialysis was required in only one patient (this 
patient had preoperative renal dysfunction). Lass common morbidities noted were new 
onset neurological dysfunction, pericardial effusions (2 patients required pericardiostomy 
for evacuation of the effusion), hepatic dysfunction and gastrointestinal bleeding. There 
were no vascular complications related to the femoral vessels secondary to the 
cannulation for vascular access. This should encourage the liberal use of femorofemoral 
bypass in reducing the possible complications of sternal re-entry as is evidenced by our 
study where we report a zero incidence of catastrophic hemorrhage. 
Follow up has not been long enough to allow us to draw any conclusions about 
the effect of operation on late survival. The bulk of reoperations were done in the last 4 
years of the study period. Nevertheless it is quite encouraging that we have observed no 
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late cardiac related deaths to date. Moreover, the quality of life has been substantially 
improved with most of the followed up patients having resumed normal physical activity 
following corrective surgery. 
Notably, various technical strategies described to reduce the risk of reoperation 
have focused on techniques of resternotomy, alternative surgical access including 
minimally invasive incisions and thoracotomy, myocardial protection and avoiding 
cardiopulmonary bypass. Different combinations of these techniques have also been 
associated with good outcomes. Improved monitoring facilities in intensive care units 
would also have contributed to a reduction in operative mortality despite an older 
population.  
Matsuyama et al (4) reported a low operative mortality rate of 4.2% for 
reoperative mitral valve surgery with Rheumatic heart disease. They demonstrated that 
higher age and advanced NYHA class were independent risk factors of lower survival 
rate. This study has also focused on late morbidity and higher age, previous MVR, and 
preoperative advanced NYHA class were independent risk factors in multivariate 
analyses. Of these risk factors, patient age was the most significant risk factor of cardiac 
events. 
Cohn and coworkers found that New York Health Association class IV and 
emergency operation were significant factors in raising the mortality of reoperation. 
Otherwise, they found no difference in the mortality of reoperation and primary heart 
valve replacement (15). 
Pansini et al (22) reported a operative mortality of 8.7% and according to their 
study, Advanced NYHA functional class, emergency operation and previous 
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thromboembolism were independent determinants of operative mortality. Postoperative 
complications were not significantly greater than after a re-do procedure than after a 
primary operation. They also agree that survival can be improved if conditions leading to 
myocardial damage can be prevented, ie, reoperation is prompt when necessary.  
Kuralay et al (19) reported cardiac reoperation using the Carpentier Bicaval 
femoral venous cannula which was specifically designed for minimally invasive 
procedures. They reported six severe cardiac injuries in the group where cardiopulmonary 
bypass was initiated after sternal re-entry in comparison with no injury when 
cardiopulmonary bypass was initiated first. Similar to our opinion, they concluded that 
although the policy of initiating cardiopulmonary bypass first increases total bypass time, 
it has its share of advantage in that the operation time, bleeding and blood transfusion 
requirement were significantly reduced. 
Tekumit et al (21) reported a mortality rate of 4.2% after valvular reoperations. 
However the study did not look into the contributing factors towards mortality. 
Wauthy et al (7) in a review of redo valve surgery reported that the mortality has 
decreased over the years from as high as 41% in the early 80’s to 8% at present. 
Functional statuses at reoperation, the degree of urgency of reoperation were reported as 
the primary risk factors for operative mortality. Other risk factors of secondary influence 
were valve position, double valve replacement, need for tricuspid valve surgery and 
prosthetic valve endocarditis. 
Kumar et at (8) reported an overall mortality following reoperation at the mitral 
position. They concluded that factors responsible for higher mortality are active infective 
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endocarditis, higher preoperative NYHA class and valve thrombosis. Emergency surgery 
and previous thromboembolism were reported to be significant factors. 
Potter et al (6) reported an overall mortality of 4.9% following reoperation at the 
aortic position and concluded that advanced functional class and reduced ejection fraction 
were the most important predictors of operative risk and reiterated the importance of 
early referral of patients for surgery before decompensation. 
Brandao et al (16) reported an overall mortality of 10.9%. Consistent with our 
findings, they also reported NYHA functional class, renal insufficiency, cardiopulmonary 
bypass time and aortic cross clamp time were important factors that  determined 
operative mortality. 
Ahujuo et al (6) in areview of reoperative cardiac surgery opined that reoperative 
cardiac surgery is still an independent factor of operative mortality. According to their 
study, operative mortality for reoperative surgery was almost 2-fold compared to the 
primary operation. 
Jones et al (10) reported on their study of repeat heart valve surgery which 
included CABG. They reported  an operative mortality of 8.6%.Highest mortality was for 
patients who underwent reopearation for endocarditis or valvular 
throbosis((~30%).Mortality was 6.4%,7.4% and 11.5% for aortic, mitral and 
double(mitral and aortic) valve replacements. They identified age,CABG,indication for 
surgery and replacement of a mechanical valve rather than a tissue valve as significant 
variables for operative mortality. 
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Limitations of the Study: 
1, Most information was collected retrospectively, a process that may reduce the validity 
of some data. We used personal and telephone enquiry, mailed questionnaires as well as 
outpatient clinical visit records. In view of this detailed method followed and an 
acceptably good rate of follow-up, we believe this data to be satisfactory and accurate.  
2, The small sample size is also a major limitation of the study. 
3.  A good majority of patients (24 patients) were operated in the last 3 years of study. 
Hence even a five years follow up will not be completed for patients who were operated 
after 2007. 
4, The inclusion of patients who underwent the first operation for varied etiologies, thus 
forming a heterogenous study group. The patient group includes reoperation for 
progressive disease along with patients in who valve failure has resulted from prosthetic 
dysfunction and thrombosis. This category has nothing in common with the title except 
for the fact that they may have initially had rheumatic valve disease. 
5. The predictors of adverse outcome were not identified separately for aortic and mitral 
valve reoperations because of the small number of events in the patients undergoing the 
specific operations. While we accept that aortic and mitral valve reoperations provide 
different surgical challenges, the preoperative status of the patient can have a profound 
influence on the surgical outcome. Advanced aortic and mitral valve disease would both 
present with severe symptoms, which is identified in this study as an independent 
predictor of major adverse postoperative event. 
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In conclusion, we have shown in this small series that repeat heart valve surgery 
can be performed with an acceptable operative mortality that compares favorably with 
results in other published series. However, several categories of patients have an 
increased risk of death at reoperation. These include patients with higher NYHA class,  
surgical priority, presence of infective endocarditis, preoperative renal dysfunction, 
Presence of CCF, preoperative LV function, previous surgery, present indication for 
reoperation and total CPB time. In addition, the indication for reoperation, especially 
thrombosed valves or prosthetic valve endocarditis, carries an increased risk. 
 It is important that patients with prosthetic valves undergo regular follow-up with 
assessment of valve function and should undergo earlier reoperation before severe 
ventricular dysfunction occurs. In spite of regular follow-up, it is noted that majority of 
patients present with severe symptoms at reoperation, which is a predictor of major 
adverse postoperative event, including death, after valve reoperation. Hence, surgery 
should be considered early in the management of recurrent or progressive cardiac disease 
before severe symptoms develop and compromise the outcome of reoperation. 
 In patients undergoing re-operative surgery, our unit protocol is to establish 
cardiopulmonary bypass before resternotomy and this is a valid and reproducible option 
to render cardiac reoperations safer and more expeditious in the reentry phase. The 
absence of cannulae in the operating field makes the procedure more comfortable. The 
liberal use of this strategy is recommended in redo cases is recommended. In our 
experience, there was no single instance of catastrophic hemorrhage and also it results in 
decreased total operative times and also decreased need for blood transfusions. No patient 
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experienced complications related to femoral cannulation. The Seldinger method allowed 
little vascular trauma and intraoperative patency of femoral vessels.  
Reoperative surgery continues to pose a significant challenge to the entire 
cardiothoracic team. Careful patient selection and assessment, a tailored strategy based 
on accurate risk stratification, and a team approach in the perioperative period can 
decrease the incidence of adverse events, reducing morbidity and mortality. Further 
minimization of the risk is obtained by strict adherence to sound basic surgical principles 
and techniques. Generally speaking, optimal planning for reoperation prior to 
deterioration to NYHA class III–IV levels and before unfavorable co-morbid conditions 
have arisen is imperative to ensure good outcomes. Following these guidelines in the 
modern era, elective reoperative surgery can be performed with results similar to those of 
the primary operation. 
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 PROFORMA FOR RETROSPECTIVE STUDY OF A 10 YEAR FOLLOW UP 
PERIOD OF PATEINTS UNDERGOING REOPERATIVE VALVE SURGERY 
 
NAME               :                                                           HOSPITAL NO: 
AGE                  :                                                            SEX          : M/F 
ADRESS           : 
DATE OF ADMISSION   :                                              
DATE OF SURGERY      : 
DATE OF DISCHARGE  : 
DATE OF DEATH           : 
FINAL DIAGNOSIS        : 
 
PREOPERATIVE DETAILS: 
 
SYMPTOMS  
TYPE OF LESION                                          : 
SYMPTOMS                                                   : 
NYHA CLASS I/ II/ III/ IV                            : 
PRESENCE OF ATRIAL FIBRILLATION  : 
PRESENCE OF CCF                                      : 
HISTORY OF RHEUMATIC HEART DISEASE : 
PENICILLIN PROPHYLAXIS                                  : 
HSTORY OF INFECTIVE ENDOCARDITIS 
HISTORY OF NEUROLOGICAL EVENT 
SMOKING/HYPERTENSION/DIABETES MELLITUS 
RENAL DYSFUNCTION 
PREVIOUS CARDIAC ETIOLOGY –RHEUMATIC HEART DISEASE 
/CONGENITAL HEART DISEASE/OTHERS  
PREVIOUS OPERATIVE PROCEDURE 
INTERVAL TO REOPERATION(YEARS)        
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OPERATIVE DATA OF THE PATIENTS AT REOPERATION: 
 
PRIORITY OF SURGERY 
SURGICAL PROCEDURE(MVR/AVR/TVR/DVR(MVR+AVR/MVR+TVR) 
CARDIOPULMONARY BYPASS TIME (MIN)  
AORTIC CROSS-CLAMP TIME (MIN)  
INOTROPIC SUPPORT 
REQUIREMENT OF IABP SUPPORT 
 
POSTOPERATIVE PERIOD/COMPLICATIONS: 
 
RE-EXPLORATION FOR BLEEDING 
DURATION OF IONOTROPIC SUPPORT-HIGH/LOW 
DURATION OF VENTILLATION-LESS THAN 24 HRS/MORETHAN 24HRS 
CODUCTION DEFECTS REQUIRING PPI 
PERICARDIAL EFFUSION  
NEUROLOGICAL DEFICIT 
WOUND INFECTION 
RENAL DYSFUNCTION 
RESPIRATORY COMPLICATIONS 
HEPATIC DYSFUNCTION 
GASTROINTESTINAL COMPLICATIONS 
ANTICOAGULATION RELATED BLEEDING 
 
CAUSES OF OPERATIVE MORTALITY: 
CARDIAC 
   LOW CARDIAC OUTPUT  
   REFRACTORY ARRHYTHMIA  
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   ENDOCARDITIS  
   ANTICOAGULATION-RELATED BLEEDING  
NON-CARDIAC 
   AIR EMBOLISM/NEUROLOGICAL EVENT  
   SEPSIS 
   RESPIRATORY COMPLICATIONS 
   MEDIASTINITIS 
REVIEW AT FOLLOW-UP VISIT 
 
DATE:                                                         6MONTH/2YR/5YR/10YR      
DURATION FROM SURGERY 
TIME OF DEATH AFTER SURGERY 
SYMPTOMS AT FOLLOW-UP 
NYHA CLASS I, II, III, IV 
LATE MORTALITIES AND MORBIDITIES. 
CAUSES OF MORTALITY 
        CARDIAC 
            VALVE-RELATED 
                  ENDOCARDITIS  
                  ANTICOAGULATION-RELATED HEMORRHAGE  
                  VALVE THROMBOSIS 
            NON-VALVE-RELATED 
                  CCF 
                  ARRHYTHMIA  
       NON-CARDIAC 
             RENAL FAILURE  
             RESPIRATORY COMPLICATIONS  
             UNKNOWN  
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FOLLOW UP COMPLICATIONS 
       ANTICOAGULATION-RELATED HEMORRHAGE  
           MINOR  
           MAJOR REQUIRING HOSPITALIZATION  
       THROMBOEMBOLIC EPISODES 
       ANEMIA  
      POSTOPERATIVE IE TREATED MEDICALLY 
 
                                                       
 
 
 
